DVT of lower extremities and pulmonary embolism

I9_DVTANDPULM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_PHLETHROMBDVTLOW I9_PULMEMB	23961
6. Filter based on genotype QC (FinnGen only)	21478

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF9

NAME	I9_DVTANDPULM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_PHLETHROMBDVTLOW\|I9_PULMEMB
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to DVT of lower extremities and pulmonary embolism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	21478	11196	10282
Unadjusted period prevalence (%)	4.33	3.97	4.71
Median age at first event (years)	64.12	62.98	65.36

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
22114: Matched controls
220122

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN4BD

NOMESCO Finland

Extensive body CT

2.3

322.7

2857

13466

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

320.7

5284

31284

Z51.5

ICD-10 Finland

Palliative care

2.3

314.1

2721

12699

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

191.2

307.7

2399

140

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

6.4

307.7

6751

14090

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

12674

84668

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

307.7

5612

32009

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

11.1

307.7

1235

1171

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

307.7

4143

17895

K93

ICPC

Pulmonary embolism

101.0

307.7

1434

151

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

106.8

307.7

5720

717

B01AF02

ATC

apixaban; oral

3.8

307.7

6147

20139

H02AB02

ATC

dexamethasone; systemic

2.4

307.7

3202

14353

I26

ICD-10 Finland

Pulmonary embolism

103.8

307.7

1315

134

K94

ICPC

Phlebitis/thrombophlebitis

11.5

307.7

1031

929

D68.8

ICD-10 Finland

Other specified coagulation defects

14.5

307.7

707

499

N02AA05

ATC

oxycodone; systemic

2.2

307.7

5568

29488

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

307.7

7502

44384

GD2SN

NOMESCO Finland

Lung ventilation SPECT

13.0

307.7

441

345

B01AB10

ATC

tinzaparin; parenteral

3.6

307.7

4169

13287

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

1462.2

307.7

3877

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

7.5

307.7

1513

2132

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

31.2

307.7

920

306

4151A

ICD-9 Finland

Acute pulmonary heart disease, Pulmonary embolism and infarction

+∞

307.7

464

JN4AD

NOMESCO Finland

Body CT examination

2.2

307.7

3351

16191

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

5.2

307.7

1713

3515

B01AF01

ATC

rivaroxaban; oral

3.2

307.7

4874

17814

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

307.7

3339

16424

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

10.5

307.7

1164

1158

I87.0

ICD-10 Finland

Postthrombotic syndrome

29.4

307.7

263

R06.0

ICD-10 Finland

Dyspnoea

2.6

307.7

8490

42923

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

93.9

307.7

4491

596

130

Kela drug reimbursment

Malignant tumour

2.4

307.7

2656

11632

C03CA01

ATC

furosemide; systemic

1.9

307.7

9057

57844

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

6.8

307.7

704

1052

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1672.0

307.7

12467

170

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.3

307.7

1386

4412

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

10.1

307.7

2729

3039

B01AB05

ATC

enoxaparin; parenteral

4.0

307.7

11721

48838

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

428.9

307.7

709

R60.0

ICD-10 Finland

Localized oedema

2.1

307.7

3621

18527

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

8.4

307.7

765

933

GD1UN

NOMESCO Finland

Lung circulation SPECT

13.5

307.7

359

268

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

307.7

4756

25582

B01AA03

ATC

warfarin; systemic

5.3

307.7

9977

29582

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

8.9

307.7

5312

7559

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

307.7

1366

B01AB04

ATC

dalteparin; parenteral

4.0

307.7

2067

5537

N02AX02

ATC

tramadol; systemic, rectal

1.7

299.2

10071

72961

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

298.9

5468

33349

H02AB06

ATC

prednisolone; systemic

1.7

298.1

10977

81391

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

291.8

3457

18208

M79.6

ICD-10 Finland

Pain in limb

1.7

286.8

9779

70820

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

285.6

3048

15430

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

260.5

250

A04AA01

ATC

ondansetron; systemic, rectal

2.3

255.8

2146

9837

A02BC02

ATC

pantoprazole; systemic

1.7

253.1

15313

126382

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

250.3

4667

28407

A46

ICD-10 Finland

Erysipelas

1.9

245.6

3862

22285

R50.9

ICD-10 Finland

Fever, unspecified

1.9

245.4

3617

20438

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.9

243.2

1176

4124

J01MA12

ATC

levofloxacin; systemic

1.8

235.0

4535

27819

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

5.4

228.8

459

863

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

227.4

2883

15448

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

226.7

5633

37024

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

219.0

3847

22891

A04AA02

ATC

granisetron; systemic, transdermal

2.4

217.4

1616

7009

R02

ICPC

Shortness of breath/dyspnoea

1.8

206.0

3356

19480

AA1AD

NOMESCO Finland

CT of head and brain

1.6

200.2

6965

49471

45001

ICD-8 Finland

Pulmonary embolism and infarction, Embolia

+∞

199.9

192

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

197.7

2379

12478

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

195.9

1590

7156

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.8

195.7

1040

3830

N03AX16

ATC

[U] pregabalin

1.7

194.6

5123

33959

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

193.7

8906

67204

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

193.5

6701

47460

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

193.5

1686

7815

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

190.3

2815

15817

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.8

190.1

1022

3786

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.1

187.9

833

2776

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

5.9

185.2

336

575

R4110

NOMESCO Finland

Physiotherapy

1.6

181.0

6101

42806

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

176.7

3363

20361

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

7.7

174.8

246

322

ZX120

NOMESCO Finland

Intravenous

2.0

172.5

2173

11551

L01BC06

ATC

capecitabine; oral

2.6

171.6

1025

4002

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

171.5

4164

26914

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

170.9

2573

14506

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

163.9

7759

58316

R03AC02

ATC

salbutamol; inhalant

1.5

162.8

11086

89494

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

161.6

1818

9278

N02BE01

ATC

paracetamol; systemic, rectal

1.8

161.5

19297

175326

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

161.4

1920

9994

WX892

NOMESCO Finland

Monitored bed care

2.0

159.4

1836

9447

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

158.1

7569

56909

ZXD05

NOMESCO Finland

Urgent procedure

1.5

154.9

6234

45174

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.2

154.9

649

2091

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

154.6

9069

70879

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

150.2

5304

37317

J01FF01

ATC

clindamycin; systemic

1.5

148.5

5582

39796

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

147.8

3609

23260

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

146.5

3537

22726

K99

ICPC

Cardiovascular disease other

2.8

146.0

783

2892

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

144.3

1276

5931

J01DB01

ATC

cefalexin; oral

1.5

143.7

17263

153722

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.9

143.7

679

2343

PH2AE, ,

SPAT

3.3

142.8

542

1644

D68.9

ICD-10 Finland

Coagulation defect, unspecified

9.7

142.7

166

171

R03BB04

ATC

tiotropium bromide; inhalant

1.8

142.2

2441

14274

A28

ICPC

Limited function/disability NOS

1.6

140.6

4501

30913

L28

ICPC

Limited function/disability (L)

1.6

139.5

4563

31482

J01MA02

ATC

ciprofloxacin; systemic

1.4

139.5

8514

66636

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

138.1

1205

5569

I82

ICD-10 Finland

Other venous embolism and thrombosis

10.7

137.4

149

139

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

136.7

2059

11564

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

135.8

3809

25344

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

135.5

2187

12544

SPAT1254

SPAT

Administration of medicine

1.6

133.7

3334

21550

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

133.3

6220

46157

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

133.3

3696

24513

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

133.2

7299

55859

J01MA14

ATC

moxifloxacin; systemic

1.9

132.3

1984

11122

WZC30

NOMESCO Finland

Teaching

1.6

131.9

3528

23190

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

131.6

3058

19409

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

9.9

130.5

150

152

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

130.5

1419

7134

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

12.6

129.0

126

100

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

127.3

7093

54334

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

127.3

2308

13687

Z3226

NOMESCO Finland

Physiotherapist

1.6

127.0

3739

25118

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

126.8

2322

13809

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

125.1

4006

27420

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

28.0

124.2

L14

ICPC

Leg/thigh symptom/complaint

1.8

123.5

1863

10452

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

122.6

1219

5924

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

122.5

3852

26246

J96.1

ICD-10 Finland

Chronic respiratory failure

2.8

121.7

615

2200

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

119.5

3600

24276

A08

ICPC

Swelling

2.0

117.8

1423

7418

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

116.7

1157

5615

S97

ICPC

Chronic ulcer skin

1.9

116.2

1569

8492

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

116.0

10021

82420

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

115.3

1120

5392

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

114.8

7244

56484

M04AA01

ATC

allopurinol; systemic

1.6

114.6

3101

20374

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

114.5

2955

19195

128

Kela drug reimbursment

Cancers of female genital organs

3.2

114.3

453

1411

L17

ICPC

Foot/toe symptom/complaint

1.4

114.1

6322

48158

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.0

112.7

514

1738

A06AD11

ATC

lactulose; oral

1.5

110.4

3493

23771

SPAT1255

SPAT

Intravenous administration of medicine

1.9

110.1

1494

8094

UJF32

NOMESCO Finland

Coloscopy

1.4

109.7

5643

42344

E66.8

ICD-10 Finland

Other obesity

2.1

108.6

1027

4892

Z3231

NOMESCO Finland

Registered nurse

1.4

107.6

5565

41777

WW500

NOMESCO Finland

Blood transfusion

2.2

107.5

939

4333

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

12.0

107.2

108

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

106.5

5976

45505

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.6

105.1

616

2378

SPAT1229

SPAT

Assessment of need for aid

1.8

104.1

1793

10447

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

157.2

104.1

110

A04AA55

ATC

palonosetron, combinations; systemic

2.4

103.1

732

3093

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.2

102.4

405

1260

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

102.2

936

4402

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

101.6

2156

13303

R53

ICD-10 Finland

Malaise and fatigue

1.4

100.7

5256

39437

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

99.7

868

3999

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

99.5

881

4087

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

98.3

1378

7536

B01AX05

ATC

fondaparinux; parenteral

4.2

97.9

265

638

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

19.5

97.6

A06AH03

ATC

naloxegol; oral

3.2

97.2

387

1209

L03AA13

ATC

pegfilgrastim; parenteral

2.1

97.1

933

4468

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

97.1

3437

23896

L03AA02

ATC

filgrastim; parenteral

2.4

96.5

677

2844

H02AB07

ATC

prednisone; oral

1.6

96.5

2837

18940

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

96.1

1006

4977

SPAT1263

SPAT

Sampling

1.4

94.9

8161

66362

L04AA06

ATC

mycophenolic acid; systemic

3.0

94.4

436

1485

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

94.1

629

2585

N05CF01

ATC

zopiclone; oral

1.4

94.1

6832

54085

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

93.9

3939

28315

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

93.0

2714

18078

Z2446

NOMESCO Finland

Social worker

1.9

92.3

1220

6544

N03AX12

ATC

[U] gabapentin; oral

1.5

91.5

3189

22072

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

91.3

779

3559

WX882

NOMESCO Finland

High dependency care

2.4

91.2

635

2658

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

90.8

436

1517

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

7.8

90.6

125

160

R4190

NOMESCO Finland

Nutritional therapy

2.2

89.6

748

3387

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

89.3

705

3119

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.4

88.8

608

2526

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

88.8

2697

18113

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

88.3

1028

5281

TGC00

NOMESCO Finland

Bronchial lavation

2.4

88.1

608

2535

R11

ICD-10 Finland

Nausea and vomiting

1.7

87.9

1778

10813

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

86.9

3303

23246

C03DA01

ATC

spironolactone; oral

1.5

86.0

2802

19097

PH7AC

NOMESCO Finland

Lumbal cavography with X-ray

49.9

86.0

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

86.0

1489

8673

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

3.5

85.6

293

832

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

5.3

85.4

172

325

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

84.3

809

3871

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

37.1

83.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

83.1

1102

5912

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

83.0

427

1542

C02KX04

ATC

macitentan; oral

20.3

82.4

J01FA06

ATC

roxithromycin; oral

1.3

82.4

7650

62540

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

9.0

82.2

101

112

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

81.4

864

4292

WF004

NOMESCO Finland

Palliative radiotherapy

2.5

81.2

523

2112

C02KX05

ATC

riociguat; oral

787.9

80.3

ZXE00

NOMESCO Finland

One hour or less

1.3

79.8

7408

60480

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

79.6

1511

9025

I27.0

ICD-10 Finland

Primary pulmonary hypertension

8.3

78.9

104

126

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

78.4

961

5022

R52.9

ICD-10 Finland

Pain, unspecified

1.6

78.3

2054

13315

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.5

77.9

508

2064

H02AB09

ATC

hydrocortisone; systemic

2.6

77.3

473

1864

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

7.5

77.3

110

146

N05BA04

ATC

oxazepam; oral

1.4

77.3

5146

39919

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

77.1

1755

10991

127

Kela drug reimbursment

Transplant complication

3.1

77.0

335

1103

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

76.7

2232

14813

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

76.7

1342

7833

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.3

76.5

297

914

H02AB04

ATC

methylprednisolone; systemic

1.5

76.4

2821

19695

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

76.0

842

4247

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

75.9

1073

5874

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

75.1

1408

8376

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

74.7

621

2806

L04AX01

ATC

azathioprine; systemic

2.0

74.3

794

3953

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

74.1

843

4291

A02BC01

ATC

omeprazole; systemic

1.4

74.0

5501

43356

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

73.9

1285

7485

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

73.8

1690

10594

G47.3

ICD-10 Finland

Sleep apnoea

1.4

73.8

4324

32820

N05AH04

ATC

quetiapine; oral

1.5

73.5

3093

22137

N06AX11

ATC

mirtazapine; oral

1.3

73.0

6616

53655

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

72.9

1088

6055

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

72.9

1539

9449

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.4

72.3

260

763

C07AB07

ATC

bisoprolol; oral

1.3

72.2

10603

91681

S18

ICPC

Laceration/cut

1.3

72.1

9526

81245

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

71.9

1371

8192

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

71.7

4523

34718

M05BX04

ATC

denosumab; parenteral

1.7

71.3

1386

8325

FB1BC

NOMESCO Finland

Extensive angiography of arteria pulmonalis

17.5

71.0

B01AF03

ATC

edoxaban; oral

2.3

70.9

578

2590

FB1ST

NOMESCO Finland

Catheter-based therapy of pulmonary embolism

+∞

70.7

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

70.6

898

4749

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

70.6

724

3551

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.6

70.4

414

1601

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.8

69.9

1138

6502

J94.8

ICD-10 Finland

Other specified pleural conditions

2.6

69.7

418

1632

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

69.7

1080

6080

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

69.6

1532

9503

J01DA01

ATC

[U] cefalexin

1.3

69.6

12099

106667

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.8

69.6

359

1299

UKC02

NOMESCO Finland

Cystoscopy

1.4

69.4

3437

25313

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

69.2

702

3429

XG466

NOMESCO Finland

Sleep oxymetry

2.1

68.6

631

2969

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

68.2

1398

8512

N06AX16

ATC

venlafaxine; oral

1.5

68.1

2327

15965

M10.9

ICD-10 Finland

Gout, unspecified

1.6

67.9

1526

9516

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.4

67.5

495

2121

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

67.1

1073

6096

A02BC05

ATC

esomeprazole; systemic

1.3

67.0

7929

66462

R03DC03

ATC

montelukast; oral

1.4

66.7

2857

20482

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

66.7

653

3147

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

12.5

66.2

J46

ICD-10 Finland

Status asthmaticus

2.2

65.5

593

2773

I50.0

ICD-10 Finland

Congestive heart failure

1.6

65.2

1852

12203

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.7

65.1

358

1339

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

65.0

1457

9075

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.9

65.0

851

4543

X58

ICD-10 Finland

Exposure to other specified factors

1.5

64.4

2592

18355

Z2221

NOMESCO Finland

Medical doctor

1.3

64.3

5028

39778

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

64.2

3017

21988

WX402

NOMESCO Finland

General anaesthesia

1.4

64.0

4039

30926

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

64.0

1313

7995

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

63.9

1407

8722

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

63.9

1047

5989

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.1

63.9

271

880

WX002

NOMESCO Finland

Sedation and analgesia

1.4

63.8

3740

28302

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

63.7

2502

17635

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

63.4

569

2652

N05BA01

ATC

diazepam; systemic, rectal

1.5

63.3

2473

17409

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

63.0

907

4990

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

63.0

2022

13680

E0000UV, ,

ATC

1.3

62.9

7899

66558

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

62.2

1067

6184

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

62.2

3463

25971

T82

ICPC

Obesity

2.0

62.0

693

3506

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

61.8

1078

6278

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

61.4

880

4833

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

61.4

630

3090

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

61.2

759

3978

R03BA05

ATC

fluticasone; inhalant

1.4

60.7

3224

23977

SPAT1301

SPAT

No procedures

1.3

60.5

6073

49653

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.1

60.4

252

810

N05AH03

ATC

olanzapine; systemic

1.8

60.2

1031

5973

RT360, ,

NOMESCO Finland

14.6

60.1

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

60.1

847

4629

GD1CN

NOMESCO Finland

Lung circulation isotope imaging

17.5

59.8

R52.0

ICD-10 Finland

Acute pain

2.1

59.5

617

3037

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

59.4

800

4309

N06AB04

ATC

citalopram; systemic

1.4

59.3

3841

29490

R51.80

ICD-10 Finland

Headache

1.4

59.2

2597

18669

N30.0

ICD-10 Finland

Acute cystitis

1.4

59.1

3304

24774

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

59.1

300

1077

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.5

59.0

1879

12683

J01AA02

ATC

doxycycline; systemic

1.3

58.9

15765

144972

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

58.6

704

3650

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.0

58.4

260

868

K07

ICPC

Swollen ankles/oedema

1.7

58.4

1072

6331

A04

ICPC

Weakness/tiredness general

1.4

58.3

3087

22936

P01AB01

ATC

metronidazole; oral, rectal

1.3

58.3

7291

61243

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

57.6

3516

26727

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.4

57.5

418

1784

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.2

57.4

481

2181

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

57.3

7209

60559

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

57.0

882

4959

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

56.9

7492

63268

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

56.9

3265

24569

J45.8

ICD-10 Finland

Mixed asthma

2.0

56.8

591

2913

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

56.7

1767

11866

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

6.4

56.4

145

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

5.4

56.4

110

202

SPAT1262

SPAT

Handing over of treatment supplies

1.4

56.3

3393

25732

R04.2

ICD-10 Finland

Haemoptysis

1.9

56.3

725

3849

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

56.1

1362

8643

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.3

55.9

428

1869

WX872

NOMESCO Finland

Intensive care

1.7

55.9

1017

5992

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

78.7

55.8

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

5.4

55.7

109

201

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

55.4

4294

33815

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

55.3

1564

10281

N02BF02

ATC

pregabalin; oral

1.6

55.2

1254

7829

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

55.0

3654

28122

JAH00

NOMESCO Finland

Laparotomy

2.0

54.5

569

2809

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

54.3

719

3850

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.9

54.2

678

3563

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

54.2

2388

17160

SPAT1216

SPAT

Assessment of functional ability

1.4

54.2

3234

24471

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

53.7

600

3035

R03BA02

ATC

budesonide; inhalant

1.4

53.6

3179

24027

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

53.6

2384

17163

N05AA02

ATC

levomepromazine; systemic

1.9

53.4

712

3822

A01

ICPC

Pain general/multiple sites

1.5

53.2

1963

13639

JAL30

NOMESCO Finland

Omentectomy

2.9

53.2

246

840

RT172, ,

NOMESCO Finland

10.3

53.1

FBB20

NOMESCO Finland

Thrombendarterectomy of pulmonary artery in chronic obstruction

+∞

53.0

L01BC59

ATC

trifluridine, combinations; systemic

5.0

52.8

112

222

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.2

52.5

466

2162

R07.3

ICD-10 Finland

Other chest pain

1.5

52.5

1993

13925

K78

ICPC

Atrial fibrillation/flutter

1.5

52.3

1716

11643

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

52.1

2197

15656

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

52.1

1032

6219

M54.5

ICD-10 Finland

Low back pain

1.3

52.0

6664

55941

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

52.0

606

3111

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

51.9

412

1827

J96.0

ICD-10 Finland

Acute respiratory failure

2.6

51.4

298

1145

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

51.3

2077

14688

ZXA05

NOMESCO Finland

Left side

1.3

51.2

4802

38751

R55

ICD-10 Finland

Syncope and collapse

1.4

50.9

2299

16586

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

50.6

899

5259

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.0

50.6

144

361

W19

ICD-10 Finland

Unspecified fall

1.5

50.5

1940

13580

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

50.4

7102

60226

B01AE07

ATC

dabigatran etexilate; oral

1.8

50.1

788

4451

R5110, ,

SPAT

1.5

50.1

1784

12303

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

50.0

1919

13431

PH2ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance

71.3

49.9

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.6

49.8

289

1111

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.8

49.8

251

898

ZX108

NOMESCO Finland

Inhalation

3.5

49.8

175

507

N06AA09

ATC

amitriptyline; systemic

1.5

49.7

1789

12363

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

49.7

426

1950

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

2.8

49.7

244

861

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

49.7

816

4669

PHD99

NOMESCO Finland

Resection of other vein

1.6

49.4

1089

6744

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.4

49.4

330

1357

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

49.4

1621

10994

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

1.9

49.3

658

3534

J01EA01

ATC

trimethoprim; systemic

1.3

48.8

4908

39925

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

48.8

484

2345

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

48.6

4957

40393

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

48.6

13396

121954

ZXA00

NOMESCO Finland

Right side

1.3

48.5

5109

41799

N05AX12

ATC

aripiprazole; systemic

2.0

48.4

517

2574

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

48.2

1193

7600

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

48.2

725

4041

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

48.1

512

2546

SPAT1211

SPAT

Application of soft bandage

1.5

48.0

1598

10866

L15

ICPC

Knee symptom/complaint

1.3

47.9

4633

37488

R31

ICD-10 Finland

Unspecified haematuria

1.4

47.7

2118

15222

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

47.4

2009

14319

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.5

47.3

295

1175

TK800

NOMESCO Finland

Hemodialysis

2.2

47.0

419

1949

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

46.9

1295

8459

J45

ICD-10 Finland

Asthma

1.5

46.8

1800

12594

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.9

46.8

227

796

PH7ZT

NOMESCO Finland

Intravenous removal of filter to inferior vena cava

86.5

46.7

WX722

NOMESCO Finland

PEEP

1.7

46.7

871

5164

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.8

46.6

243

885

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

46.6

646

3511

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

46.5

2409

17779

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

46.4

951

5781

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

46.1

3741

29548

R03AC03

ATC

terbutaline; inhalant

1.4

46.1

2376

17519

RT274, ,

NOMESCO Finland

7.9

46.0

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.4

46.0

308

1268

I82.21

ICD-10 Finland

Emboli and thrombosis in the inferior vena cava

12.1

45.9

GD1FN

NOMESCO Finland

Lung ventilation isotope imaging

12.9

45.7

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.1

45.7

453

2195

R06.2

ICD-10 Finland

Wheezing

1.7

45.5

773

4465

A07AA02

ATC

nystatin; oral

1.6

45.4

1136

7253

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

45.3

3793

30079

N03AX14

ATC

levetiracetam; systemic

1.9

45.2

539

2788

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.9

45.1

627

3410

GD1FQ

NOMESCO Finland

Lung ventilation SPECT with low dose CT

16.5

45.0

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

45.0

477

2368

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

2.8

44.9

232

842

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

44.8

1160

7465

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.6

44.7

255

973

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

44.6

942

5769

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.3

44.6

340

1483

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.5

44.6

275

1090

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

44.6

413

1950

A41.8

ICD-10 Finland

Other specified sepsis

2.1

44.5

406

1906

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

44.4

1137

7299

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

44.3

511

2613

R81

ICPC

Pneumonia

1.8

44.2

723

4132

A29

ICPC

General symptom/complaint other

1.4

44.1

2619

19747

B03XA02

ATC

darbepoetin alfa; parenteral

2.1

44.0

429

2065

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.5

43.7

275

1100

L16

ICPC

Ankle symptom/complaint

1.4

43.7

2019

14605

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

43.5

1590

11010

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

43.5

895

5445

R06AE07

ATC

cetirizine; oral

1.2

43.4

7709

66751

R03DA04

ATC

theophylline; systemic, rectal

1.6

43.3

1055

6692

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

43.2

514

2658

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

43.2

461

2295

WW200

NOMESCO Finland

Immunization

2.0

43.1

484

2453

L04AD02

ATC

tacrolimus; systemic

3.0

42.9

191

639

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.7

42.7

729

4217

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

42.7

1779

12630

R42

ICD-10 Finland

Dizziness and giddiness

1.3

42.6

4678

38366

A11CC03

ATC

alfacalcidol; systemic

2.0

42.5

461

2307

N03AX09

ATC

lamotrigine; oral

1.8

42.5

666

3757

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

42.3

7018

60284

SPAT1240

SPAT

Therapeutic discussion

1.5

42.3

1409

9578

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

42.2

785

4651

A07AA09

ATC

vancomycin; oral

2.3

42.1

312

1344

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

42.1

563

3025

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

42.0

5317

44330

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

42.0

2466

18552

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

42.0

441

2183

L01AX03

ATC

temozolomide; systemic

3.3

41.9

156

469

E86

ICD-10 Finland

Volume depletion

1.9

41.9

546

2910

A04AD12

ATC

aprepitant; systemic

2.2

41.7

356

1627

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

41.6

1425

9742

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

41.3

1856

13352

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.9

41.2

489

2526

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

41.2

2248

16713

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.6

41.1

243

944

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

40.8

1296

8721

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

40.8

1268

8496

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

40.7

616

3440

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

40.7

2601

19820

J01CA04

ATC

amoxicillin; systemic

1.2

40.6

15767

147131

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

40.5

1121

7324

N19

ICD-10 Finland

Unspecified kidney failure

1.7

40.3

783

4691

SPAT1260

SPAT

Consultation of another employee

1.3

40.3

3178

24955

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

40.2

1137

7462

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

40.0

561

3061

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.8

40.0

572

3140

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

2.4

39.9

268

1106

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.0

39.8

408

2001

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

2.8

39.5

193

680

Z94.0

ICD-10 Finland

Kidney transplant status

2.7

39.5

210

774

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

39.4

660

3796

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

39.4

3725

29953

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

39.3

2177

16215

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

39.2

2914

22685

FXA20

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure

9.0

39.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

39.1

7835

68460

N05CD07

ATC

temazepam; oral

1.4

39.1

2372

17926

TPX15

NOMESCO Finland

Removal of vascular injection port

3.8

39.0

119

314

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.0

38.9

444

2263

L04AD01

ATC

ciclosporin; systemic

2.2

38.6

312

1395

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

38.4

1382

9534

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.1

38.3

346

1618

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.0

38.2

415

2079

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

38.2

563

3119

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.4

38.2

255

1050

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

38.2

476

2501

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.9

38.1

514

2770

N02AA01

ATC

morphine; systemic, rectal

2.0

37.9

410

2052

I81

ICD-10 Finland

Portal vein thrombosis

4.0

37.8

108

272

R52.2

ICD-10 Finland

Other chronic pain

1.7

37.8

656

3813

RS221, ,

NOMESCO Finland

2.4

37.7

254

1050

WX320

NOMESCO Finland

Spinalanesthesy

1.3

37.7

4624

38334

R4120

NOMESCO Finland

Occupational therapy

1.5

37.7

1123

7454

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

37.6

507

2732

K92.1

ICD-10 Finland

Melaena

1.5

37.6

1079

7103

S06.0

ICD-10 Finland

Concussion

1.4

37.5

1893

13887

R03AC13

ATC

formoterol; inhalant

1.6

37.2

890

5619

R18

ICD-10 Finland

Ascites

2.0

37.2

389

1923

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

37.1

1010

6573

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.4

37.1

246

1010

R10.0

ICD-10 Finland

Acute abdomen

1.8

37.0

570

3201

N06AX21

ATC

duloxetine; oral

1.4

36.9

1978

14647

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

3.5

36.9

129

373

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

36.4

261

1110

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

36.3

2401

18369

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

36.3

636

3707

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.5

36.1

122

345

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.7

36.1

200

753

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

36.0

3557

28721

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

36.0

762

4670

M01AH02

ATC

rofecoxib; oral

1.3

35.9

2381

18217

SPAT1125

SPAT

Stoma care and guidance

2.1

35.9

361

1760

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.9

35.9

431

2237

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

35.9

1479

10469

M03BX02

ATC

tizanidine; oral

1.2

35.8

11125

100961

C56

ICD-10 Finland

Malignant neoplasm of ovary

3.2

35.7

139

430

K29

ICPC

Cardiovascular sympt/complt other

1.6

35.7

881

5603

C90.0

ICD-10 Finland

Multiple myeloma

2.4

35.7

239

985

L01CA04

ATC

vinorelbine; systemic

2.7

35.7

192

712

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

35.5

685

4097

A03

ICPC

Fever

1.3

35.4

2573

19945

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

35.3

3064

24332

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.8

35.2

175

623

NF3AA

NOMESCO Finland

Femur X-ray examination

1.9

35.2

444

2343

TJF80

NOMESCO Finland

Ostomy education

2.5

35.1

224

903

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.0

35.1

406

2080

WVA20

NOMESCO Finland

Medicine administration

1.8

35.1

517

2865

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

35.0

830

5229

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

2.8

34.9

180

653

S76

ICPC

Skin infection other

1.5

34.9

970

6340

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.9

34.9

418

2168

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

34.6

4508

37570

JAH01

NOMESCO Finland

Laparoscopy

1.7

34.6

711

4325

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.1

34.5

147

480

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.5

34.5

212

840

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

2.8

34.4

173

620

R06.4

ICD-10 Finland

Hyperventilation

2.3

34.2

261

1140

WX730

NOMESCO Finland

Conventional respirator

2.2

34.1

305

1422

R96

ICPC

Asthma

1.4

34.1

1714

12555

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

34.0

782

4893

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.1

33.9

333

1609

JN6AD

NOMESCO Finland

CT of torso and neck

2.1

33.9

336

1629

I28.9

ICD-10 Finland

Disease of pulmonary vessels, unspecified

9.5

33.9

E87.6

ICD-10 Finland

Hypokalaemia

1.7

33.8

659

3953

S80.0

ICD-10 Finland

Contusion of knee

1.5

33.8

1210

8337

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

33.7

1560

11267

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

3.3

33.6

127

386

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.7

33.6

185

695

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

2.2

33.5

293

1355

S22.3

ICD-10 Finland

Fracture of rib

1.4

33.4

1321

9276

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.2

33.3

297

1383

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

33.3

1768

13066

45000, ,

ICD-8 Finland

+∞

33.3

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

33.2

2140

16294

M01AX17

ATC

nimesulide; oral

1.2

33.2

4459

37260

HA1AA

NOMESCO Finland

X-ray mammography

1.4

33.1

1320

9283

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

33.0

539

3079

M25.5

ICD-10 Finland

Pain in joint

1.2

33.0

5589

47836

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.6

33.0

107

295

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

2.8

33.0

167

601

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.1

32.9

311

1481

WX721

NOMESCO Finland

Oxygen concentrator therapy

4.5

32.7

179

Z71.8

ICD-10 Finland

Other specified counselling

1.2

32.6

5896

50778

C20

ICD-10 Finland

Malignant neoplasm of rectum

2.5

32.6

204

816

R33

ICD-10 Finland

Retention of urine

1.4

32.5

1603

11704

N06AB10

ATC

escitalopram; oral

1.3

32.5

3081

24723

N03AE01

ATC

clonazepam; systemic

1.5

32.4

951

6289

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

32.4

994

6636

ZY000

NOMESCO Finland

Hospital inpatient

2.6

32.4

184

702

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

3.8

32.4

253

M48.0

ICD-10 Finland

Spinal stenosis

1.3

32.3

2429

18901

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.9

32.3

391

2035

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

32.3

852

5504

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

32.2

636

3828

SPAT1104

SPAT

Monitoring of emergency patient

1.5

32.1

1147

7898

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.1

32.1

134

433

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

32.1

372

1909

A02BC03

ATC

lansoprazole; oral

1.2

32.1

5365

45838

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

32.0

369

1889

N02BF01

ATC

gabapentin; oral

1.4

31.9

1797

13400

L04AX03

ATC

methotrexate; systemic

1.4

31.9

1586

11591

R07.1

ICD-10 Finland

Chest pain on breathing

2.2

31.9

281

1303

A79

ICPC

Malignancy NOS

2.0

31.9

328

1613

E66

ICD-10 Finland

Obesity

1.6

31.8

761

4805

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

31.8

1900

14299

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

31.8

4881

41335

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

31.8

1337

9493

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

31.7

7632

67443

J01FA10

ATC

azithromycin; systemic

1.2

31.7

9721

87733

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

31.6

557

3251

SPAT1251

SPAT

Organisation of medication

1.7

31.6

644

3910

L02BA03

ATC

fulvestrant; parenteral

3.0

31.5

141

474

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

31.4

1048

7120

XF622

NOMESCO Finland

Measurement of minute volume of heart

4.2

31.4

202

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

31.3

1068

7286

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.1

31.2

295

1406

ZY010

NOMESCO Finland

Hospital outpatient

1.6

31.2

684

4229

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

1.9

31.0

371

1925

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

30.9

1808

13559

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

30.9

691

4292

J01CA08

ATC

pivmecillinam; oral

1.2

30.9

6972

61217

R05

ICD-10 Finland

Cough

1.2

30.9

3755

31005

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

3.3

30.9

115

347

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.1

30.8

307

1492

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

42.1

30.7

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.4

30.5

211

884

ZX112

NOMESCO Finland

Subcutaneous

1.9

30.5

376

1970

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.0

30.5

136

457

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

3.7

30.4

251

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

30.3

432

2370

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.7

30.3

167

628

WF002

NOMESCO Finland

Radical radiotherapy

1.5

30.2

1001

6790

A12AA04

ATC

calcium carbonate; oral

2.1

30.2

290

1391

N06AX12

ATC

bupropion; oral

1.5

30.2

872

5749

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

2.8

30.1

150

535

R03BA01

ATC

beclometasone; inhalant

1.3

30.0

2418

18984

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

29.9

1040

7121

SPAT1234

SPAT

Support of social functional capacity

1.5

29.9

1006

6843

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

29.9

4349

36588

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

29.8

1092

7555

JMA10

NOMESCO Finland

Transabdominal total splenectomy

3.2

29.8

120

380

-50

ICPC

Medication/prescr/renewal

1.6

29.8

707

4458

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.5

29.7

1029

7041

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

29.7

864

5704

N07BC02

ATC

methadone; systemic

3.9

29.7

215

M79.1

ICD-10 Finland

Myalgia

1.3

29.5

2365

18551

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

29.5

7101

62645

L03AA14

ATC

lipegfilgrastim; parenteral

2.0

29.5

303

1490

K56.7

ICD-10 Finland

Ileus, unspecified

2.0

29.4

338

1729

M05BA04

ATC

alendronic acid; oral

1.4

29.4

1710

12815

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

29.3

1502

11031

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

29.3

1302

9334

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.8

29.2

402

2184

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.1

29.1

276

1317

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

1.8

29.1

440

2458

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.7

29.0

157

585

ZZA00

NOMESCO Finland

Split skin graft

1.7

29.0

509

2970

M02AA07

ATC

piroxicam; topical

1.2

29.0

6790

59738

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

28.9

2393

18852

P01BA02

ATC

hydroxychloroquine; oral

1.4

28.8

1340

9680

JFB00

NOMESCO Finland

Partial resection of small intestine

2.0

28.8

305

1517

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.2

28.8

229

1020

155

Kela drug reimbursment

Afatinib and gefitinib

5.9

28.7

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.9

28.7

372

1981

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.9

28.7

392

2123

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

28.7

336

1731

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

28.7

501

2919

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

28.7

1046

7231

M09AX01

ATC

hyaluronic acid; parenteral

1.5

28.6

907

6098

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

28.6

1239

8842

PH7UT

NOMESCO Finland

Removal of thrombosis from vein of lower extremity or pelvis or from vena cava inferior

103.0

28.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

28.5

12166

112384

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

28.4

1295

9323

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

28.4

569

3440

J96.9

ICD-10 Finland

Respiratory failure, unspecified

2.7

28.4

147

536

ZX121

NOMESCO Finland

Central venous catheter

3.7

28.2

232

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

28.1

6882

60736

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.2

28.0

246

1141

JFF10

NOMESCO Finland

Loop enterostomy

3.0

28.0

122

405

L01BA01

ATC

methotrexate; systemic

1.6

27.7

602

3715

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

1.9

27.6

347

1830

R03AK11

ATC

formoterol and fluticasone; inhalant

1.8

27.6

393

2157

SPAT1167

SPAT

Insertion of urinary catheter

1.6

27.6

622

3873

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

3.4

27.6

100

297

M10.0

ICD-10 Finland

Idiopathic gout

1.6

27.6

645

4053

153

Kela drug reimbursment

Lenalidomid

2.9

27.5

130

451

FB1AC

NOMESCO Finland

Angiography of arteria pulmonalis

28.4

27.5

G04BE03

ATC

sildenafil; oral

2.1

27.4

259

1235

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

27.4

372

2012

L04AX04

ATC

lenalidomide; oral

2.9

27.4

126

431

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

27.4

338

1773

N03AG01

ATC

valproic acid; systemic, rectal

1.5

27.3

910

6181

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

27.2

898

6088

K28

ICPC

Limited function/disability (K)

1.8

27.2

440

2510

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

27.1

662

4202

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

3.4

27.0

291

A02BA02

ATC

ranitidine; systemic

1.2

27.0

3560

29609

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

26.9

677

4327

N17.8

ICD-10 Finland

Other acute renal failure

2.1

26.8

248

1173

J01DA09

ATC

[U] cefadroxil

1.2

26.8

4399

37401

A99

ICPC

Disease/condition unspecnature/site

1.3

26.8

1841

14130

J01CF05

ATC

flucloxacillin; systemic

1.4

26.8

1132

8042

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.8

26.5

403

2256

R28

ICPC

Limited function/disability (R)

2.1

26.5

255

1225

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

26.5

1403

10356

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.6

26.5

345

6148

ZX095

NOMESCO Finland

Combined chemoradiotherapy

2.9

26.4

121

413

R03AC12

ATC

salmeterol; inhalant

1.5

26.3

799

5323

3012

Kela drug reimbursment

Cabozantinib

4.5

26.3

143

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.7

26.2

540

3288

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.0

26.2

287

1446

D45

ICD-10 Finland

Polycythaemia vera

2.4

26.1

185

785

SPAT1109

SPAT

Analgesia with portable analgesic pump

2.7

26.1

134

487

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.0

26.0

277

1381

45099, ,

ICD-8 Finland

+∞

26.0

45003

ICD-8 Finland

Pulmonary embolism and infarction, Thrombosis

+∞

26.0

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.7

25.9

471

2775

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

3.2

25.9

103

324

JKA20

NOMESCO Finland

Cholecystectomy

1.7

25.9

485

2881

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.5

25.9

707

4604

FB1CD, ,

NOMESCO Finland

6.3

25.8

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.3

25.8

198

869

N05AF03

ATC

chlorprothixene; systemic

1.8

25.7

373

2061

1502

Kela drug reimbursment

Cabozantinib

4.4

25.6

146

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

25.6

2077

16303

PHD76

NOMESCO Finland

Resection of long saphenous vein

1.5

25.6

745

4919

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.2

25.5

205

917

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.4

25.5

1097

7817

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.7

25.5

486

2901

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

25.5

666

4295

L04AA01

ATC

[U] ciclosporin

2.1

25.5

234

1105

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.5

25.5

807

5425

O22.8

ICD-10 Finland

Other venous complications in pregnancy

32.9

25.4

S10

ICPC

Boil/carbuncle

1.5

25.4

950

6597

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

25.4

5022

43419

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.8

25.4

352

1918

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

25.3

1544

11644

U04

ICPC

Incontinence urine

1.4

25.3

1109

7928

SPAT1172

SPAT

Guidance concerning hydration

1.7

25.2

476

2834

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

25.2

1460

10927

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

4.4

25.2

140

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.5

25.1

767

5117

L01XX05

ATC

hydroxycarbamide; oral

2.1

25.0

238

1139

D69.5

ICD-10 Finland

Secondary thrombocytopenia

3.8

25.0

192

M81.4

ICD-10 Finland

Drug-induced osteoporosis

3.2

25.0

306

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.6

25.0

612

3889

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.5

24.9

788

5295

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.3

24.9

1786

13788

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.2

24.8

208

947

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

24.8

444

2605

V03AE01

ATC

polystyrene sulfonate; oral

2.0

24.8

250

1222

P76

ICPC

Depressive disorder

1.5

24.8

829

5632

X57

ICD-10 Finland

Unspecified privation

1.8

24.7

384

2165

J20

ICD-10 Finland

Acute bronchitis

1.3

24.7

1694

12997

R04.0

ICD-10 Finland

Epistaxis

1.4

24.7

1410

10530

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

24.5

1895

14776

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

24.4

1882

14669

A12BA01

ATC

potassium chloride; oral

1.5

24.4

865

5947

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.3

24.4

189

834

C08CA01

ATC

amlodipine; oral

1.2

24.4

7836

70480

A10AB05

ATC

insulin aspart; parenteral

1.4

24.3

1292

9536

N03AF02

ATC

oxcarbazepine; oral

1.6

24.3

502

3059

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.6

24.3

588

3725

KBV00

NOMESCO Finland

Insertion of stent into ureter

2.7

24.2

131

489

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

24.2

647

4193

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

2.4

24.2

162

670

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.7

24.2

425

2482

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

2.3

24.2

178

768

SPAT1281

SPAT

Other administrative function

1.4

24.2

1234

9051

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

24.1

3646

30708

192

Kela drug reimbursment

Fulvestrant

2.9

24.1

109

370

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

24.1

592

3765

1220

FHL

Arthroscopy

1.6

24.0

626

4034

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

3.1

24.0

100

324

ZX070

NOMESCO Finland

Intensity modified radiotherapy

1.9

24.0

302

1596

J01XX08

ATC

linezolid; systemic

2.6

23.9

135

515

WX704

NOMESCO Finland

Intubation

1.4

23.9

1329

9883

N06AB03

ATC

fluoxetine; oral

1.3

23.9

1876

14659

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.6

23.9

605

3875

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

23.9

180

785

369

Kela drug reimbursment

Regorafenib

3.9

23.8

181

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

2.1

23.7

211

984

M02AA10

ATC

ketoprofen; topical

1.2

23.7

2798

22961

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

23.7

12905

120573

M25.0

ICD-10 Finland

Haemarthrosis

2.2

23.7

208

966

WX740

NOMESCO Finland

Nitrogen oxide therapy

4.3

23.6

139

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.1

23.6

231

1118

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

1.7

23.6

393

2262

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.3

23.5

181

796

M01AX05

ATC

glucosamine; oral

1.2

23.5

3647

30786

J01FA09

ATC

clarithromycin; systemic

1.2

23.5

5070

44116

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

23.5

7773

70008

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

23.5

2308

18549

N05AX08

ATC

risperidone; systemic

1.3

23.5

1541

11747

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.5

23.4

810

5541

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

5.5

23.4

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.0

23.4

244

1208

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

23.3

4605

39760

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

1.8

23.3

330

1811

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

3.7

23.2

193

N05AN01

ATC

lithium; oral

1.8

23.2

323

1762

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.8

23.2

358

2015

SPAT1252

SPAT

Overall medication plan or its review

1.4

23.2

1232

9094

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

1.4

23.2

872

6063

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

23.2

1883

14778

PG1ST

NOMESCO Finland

Endovascular arterial thrombolysis with radiological guidance not elsewhere classified

4.5

23.1

125

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

23.1

1584

12149

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018418) pH of Serum or Plasma

8978

62299

1.73

319.28

5.9

4.3

7.40

3.29

6742

44754

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6402

40321

1.82

318.40

5.1

4.1

238.98

471.06

ng/l

5.49

5363

33135

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2121

1808

12.81

307.65

1.3

1.2

3.50

4.18

u/ml

0.52

744

707

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2253

1609

15.41

307.65

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2686

4279

6.97

307.65

2.8

2.3

205.13

197.58

3.28

2508

4080

(4195642) Thrombophilia screening test

2230

1516

16.17

307.65

1.2

—

(3019977) pH of Arterial blood

5041

24882

2.32

307.65

8.7

7.3

7.42

5.66

2926

13554

(3013650) Neutrophils [#/volume] in Blood by Automated count

14496

108748

1.95

307.65

15.1

9.3

4.36

4.23

e9/l

7.47

12847

93478

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

2027

1784

12.35

307.65

1.3

1.2

3.68

4.07

u/ml

0.47

926

851

(3003396) Base excess in Arterial blood by calculation

5017

24727

2.32

307.65

8.6

7.2

1.21

0.92

mmol/l

5.77

4198

20358

(3019069) Monocytes/Leukocytes in Blood

12466

89733

1.88

307.65

8.8

6.5

8.94

9.00

1.45

11888

83657

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6193

34164

2.12

307.65

4.8

3.2

0.80

0.82

mmol/l

13.17

5907

31858

(3032080) INR in Blood by Coagulation assay

15110

95813

2.80

307.65

27.3

16.2

1.43

1.29

inr

131.79

13139

80160

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4100

20592

2.21

307.65

9.7

8.0

121.22

120.45

g/l

1.51

4011

20117

(3036489) Thrombin time

3421

5924

6.62

307.65

2.3

1.9

21.35

21.20

0.43

2764

5392

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4713

24868

2.13

307.65

2.3

1.9

—

(3018010) Neutrophils/Leukocytes in Blood

12371

89546

1.85

307.65

8.4

6.3

59.50

57.94

38.09

11953

85107

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

2269

1515

16.50

307.65

1.1

118.76

117.05

0.97

2018

1374

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3302

6249

6.01

307.65

3.7

2.7

0.38

0.34

iu/ml

8.27

2125

3295

(3013826) Glucose [Moles/volume] in Serum or Plasma

15006

116341

1.88

307.65

7.9

5.1

6.78

6.80

mmol/l

0.32

14594

110764

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4521

24969

2.01

307.65

5.0

4.2

254.10

244.80

u/l

3.45

4328

23565

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14275

104464

2.02

307.65

10.5

6.4

11.05

11.90

umol/l

14.45

13826

99397

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10572

65596

2.16

307.65

3.9

3.2

1457.53

1616.78

ng/l

2.60

9461

56801

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10360

39762

4.00

307.65

2.6

1.6

2.26

1.20

mg/l

82.19

8693

31030

(3016502) Oxygen saturation in Arterial blood

4528

22212

2.29

307.65

8.9

7.5

95.05

95.53

5.57

4371

21435

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

745

585

13.08

307.65

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6554

35641

2.18

307.65

2.4

1.9

—

(3006315) Basophils [#/volume] in Blood

13242

97430

1.88

307.65

8.4

6.2

0.04

e9/l

1.43

11452

82777

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5693

31385

2.08

307.65

3.2

2.0

30.46

29.69

11.49

5564

30516

(3023368) Bacteria identified in Blood by Culture

10120

58626

2.32

307.65

6.0

4.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

10941

78020

1.78

307.65

5.4

4.1

54.06

78.15

ng/l

0.78

8737

57705

(3042936) Bacteria identified in Isolate by Culture

4978

28582

1.95

307.65

2.4

2.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

5039

24881

2.32

307.65

8.7

7.2

11.42

12.27

kpa

28.32

4830

23871

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

480

555

8.78

307.65

1.2

1.1

20.29

9.62

u/ml

0.47

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5040

24894

2.31

307.65

8.7

7.2

5.06

5.08

kpa

0.72

4848

23887

(3006504) Eosinophils/Leukocytes in Blood

12428

89497

1.87

307.65

8.7

6.4

2.65

2.85

19.27

11847

83402

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1998

5020

4.26

307.65

3.3

2.3

3.70

3.60

g/l

1.84

1916

4793

(3002030) Lymphocytes/Leukocytes in Blood

12599

91360

1.87

307.65

8.7

6.4

25.21

26.90

53.36

12109

86148

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5027

26602

2.14

307.65

2.2

1.8

—

(3001604) Monocytes [#/volume] in Blood

13210

97093

1.88

307.65

8.4

6.1

0.62

0.60

e9/l

3.95

11428

82464

(3034426) Prothrombin time (PT)

401

378

10.74

307.65

1.2

28.95

28.01

1.50

401

378

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14010

103290

1.96

307.65

10.9

7.1

1.21

mmol/l

11.50

12268

88699

(3024561) Albumin [Mass/volume] in Serum or Plasma

12426

92338

1.77

307.65

7.6

4.9

33.66

35.28

g/l

166.88

11750

86084

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

12899

92463

1.93

307.65

9.7

6.5

1.21

mmol/l

13.27

12216

85067

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

774

681

11.69

307.65

1.2

1.1

1.08

1.06

ratio

1.70

628

551

(3013115) Eosinophils [#/volume] in Blood

13439

100194

1.85

307.65

8.8

6.3

0.19

0.20

e9/l

9.35

11786

86482

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3229

4502

8.19

307.65

2.4

2.1

97.20

90.11

45.63

3030

4358

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1733

1164

15.99

307.65

1.2

1.1

96.46

97.07

0.27

1590

1102

(3019198) Lymphocytes [#/volume] in Blood

13404

99139

1.88

307.65

8.5

6.2

1.81

1.90

e9/l

4.57

11835

86261

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

630

428

15.05

307.65

1.1

1.0

98.00

97.26

0.16

501

328

(4268621) Lupus anticoagulant assay

1467

1256

12.38

307.65

2.4

2.2

—

(3022096) Basophils/Leukocytes in Blood

12410

89527

1.87

307.65

8.8

6.5

0.63

0.67

17.35

11836

83416

(3033658) Prothrombin time (PT) actual/Normal

8219

49899

2.02

307.65

5.8

4.1

85.43

87.60

10.29

7955

48855

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4743

27500

1.91

304.75

7.4

5.7

1.04

mmol/l

0.20

4455

25398

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5270

31735

1.86

300.30

3.1

2.7

20.60

22.04

11.53

4936

29294

(3020779) Urea [Moles/volume] in Serum or Plasma

3596

19059

2.05

298.99

8.7

6.9

10.44

10.64

mmol/l

0.86

3417

18127

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5579

34237

1.83

298.88

3.0

2.6

2.27

2.29

g/l

3.20

5205

31444

(3022948) Iron [Moles/volume] in Serum or Plasma

5862

36565

1.81

297.36

3.1

2.6

11.51

12.59

umol/l

26.24

5488

33834

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

352

385

9.23

289.44

1.1

7.85

2.72

u/ml

0.85

(3014111) Lactate [Moles/volume] in Serum or Plasma

3589

19264

2.02

287.06

9.0

7.1

1.37

1.36

mmol/l

0.09

3517

18834

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2034

8724

2.45

283.12

2.3

1.9

2.55

2.20

ug/l

0.20

1819

7651

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2779

13711

2.16

277.73

4.7

3.6

5.17

5.15

kpa

0.44

2656

12994

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2739

13437

2.17

277.71

9.1

7.5

24.88

24.78

mmol/l

0.64

2719

13325

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2634

12743

2.20

276.52

10.4

9.0

24.49

24.26

mmol/l

3.28

2561

12400

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3041

15567

2.10

275.97

1.9

1.6

—

(3009343) pH of Capillary blood

2707

13298

2.17

273.25

4.7

3.6

7.42

1.75

2318

11060

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8893

63453

1.66

271.70

3.5

2.7

70.62

63.01

u/l

0.31

8414

58563

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

17359

147531

1.80

265.91

13.9

8.2

83.43

80.57

u/l

10.11

16801

139704

(3000991) Gas panel - Venous blood

3395

18318

2.00

265.77

10.5

8.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2663

13248

2.14

259.42

7.9

6.6

24.75

24.49

mmol/l

3.06

2559

12681

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2421

11623

2.21

258.05

4.5

3.4

2.14

1.84

mmol/l

3.21

1842

8562

(3044640) Blood type and Crossmatch panel - Blood

8849

63945

1.63

251.13

3.2

2.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3860

22132

1.89

250.96

5.2

4.0

41.90

24.02

ug/l

1.40

3235

18247

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1334

4957

2.79

247.84

1.9

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3769

21660

1.88

242.45

4.5

3.7

5.87

5.81

kpa

3.07

3662

21132

(3002032) Base excess in Venous blood by calculation

3694

21099

1.89

242.17

4.6

3.8

2.03

1.78

mmol/l

3.47

3248

18504

(3002582) Erythrocytes [#/volume] in Urine

9144

67055

1.61

241.37

4.7

3.5

99.36

88.81

e6/l

0.28

7268

51463

(3012544) pH of Venous blood

3799

21992

1.87

238.46

4.5

3.8

7.38

0.06

2277

12760

(3030467) Casts [#/volume] in Urine by Automated count

8100

58028

1.61

233.25

4.5

3.4

0.55

0.44

e6/l

2.16

6263

42955

(3014007) Fractional oxyhemoglobin in Arterial blood

2699

14026

2.04

232.40

11.1

9.1

93.43

93.91

3.61

2688

13980

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2635

13585

2.06

231.85

11.2

9.2

0.63

0.64

0.08

2615

13503

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2686

14043

2.03

227.11

11.0

9.0

1.35

1.32

1.19

2664

13953

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

11502

89956

1.57

224.21

3.6

2.8

—

estimate

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1310

5107

2.65

221.05

1.9

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

15225

127359

1.61

219.13

6.8

5.0

2025.42

1795.38

e6/l

0.17

277

1909

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7659

54777

1.60

218.28

2.8

2.4

3.22

2.88

mg/l

20.58

6778

47017

(3018095) Leukocytes [#/volume] in Urine

9865

74852

1.56

217.29

5.6

4.1

113.46

110.60

e6/l

0.10

7455

53489

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2383

12131

2.07

216.14

11.4

9.4

15.88

15.96

0.61

2294

11711

(36304419) Bacteria [Presence] in Urine

7631

54673

1.59

215.06

4.4

3.3

28.49

353.50

estimate

0.99

274

(3020630) Protein [Mass/volume] in Serum or Plasma

3219

18425

1.86

206.64

3.4

2.6

64.81

66.29

g/l

21.12

2969

16712

(40767503) Oxygen content in Capillary blood by calculation

1109

4249

2.68

193.22

3.3

2.6

16.18

16.25

0.28

1090

4154

(3026782) Osmolality of Urine

5812

39878

1.61

191.57

4.0

3.0

520.94

529.17

mosm/kgh2o

2.29

5260

34922

(3007853) Bacteria identified in Skin by Aerobe culture

3785

23285

1.75

189.31

2.1

1.8

—

(3027315) Oxygen [Partial pressure] in Blood

1091

4193

2.67

188.85

5.1

4.0

8.43

8.52

kpa

0.95

1069

4081

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6795

48609

1.57

186.30

3.1

2.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

9192

70252

1.52

185.89

5.2

3.4

2.35

2.36

mmol/l

10.92

8445

63278

(3000850) Epithelial cells [#/volume] in Urine

6571

46684

1.57

185.53

3.7

2.8

5.53

5.26

e6/l

0.96

6091

42486

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1597

7364

2.25

185.37

3.6

2.9

24.92

24.80

mmol/l

0.62

1570

7232

(3013290) Carbon dioxide [Partial pressure] in Blood

1070

4177

2.63

179.36

5.1

3.9

5.00

kpa

0.04

1048

4066

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1102

4367

2.59

179.15

1.7

1.4

—

(3012501) Base excess in Blood by calculation

1069

4176

2.63

178.93

5.1

3.9

2.70

2.57

mmol/l

0.77

777

2849

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3274

19683

1.77

176.26

2.4

2.2

0.20

0.21

g/l

2.90

3041

18260

(3010421) pH of Blood

1419

6374

2.30

175.06

4.9

3.6

7.41

2.08

1397

6274

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8286

62604

1.51

173.30

4.5

3.2

33.99

34.97

u/l

0.68

7834

58772

(1616796) Gas panel - Central venous blood

1128

4612

2.51

171.66

4.7

3.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

3046

18116

1.78

169.62

3.8

3.1

4.53

4.46

kpa

0.88

2951

17624

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2957

17449

1.79

169.07

3.4

3.1

195.64

230.90

ng/l

3.93

2712

16033

(3028626) Oxygen [Partial pressure] in Capillary blood

1196

5059

2.43

169.06

3.6

3.0

8.07

7.98

kpa

1.05

1167

4933

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

922

3439

2.74

168.97

2.0

1.6

—

(3027945) Reticulocytes/Erythrocytes in Blood

4002

25805

1.66

165.71

3.2

2.4

1.93

1.77

13.88

3570

22767

(3028271) Lactate [Moles/volume] in Capillary blood

852

3085

2.82

165.19

2.2

1.8

1.66

1.72

mmol/l

1.12

832

3002

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

982

3845

2.61

163.38

7.3

5.1

3917.52

1444.15

iu/ml

0.33

187

564

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8396

64242

1.49

161.75

2.7

2.2

216.57

214.88

u/l

0.06

7990

60483

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3624

22928

1.69

160.84

3.3

2.6

9.57

9.09

umol/l

0.50

3151

20081

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2222

12188

1.91

160.06

4.3

3.9

24.33

24.20

mmol/l

1.09

2193

12013

(3037467) Urinalysis macro (dipstick) panel - Urine

15212

130892

1.50

159.99

6.6

4.8

2.09

2.34

0.20

211

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

218

275

7.96

159.83

1.2

1.1

32.10

40.00

u/ml

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2964

17773

1.76

159.69

2.8

2.3

367.66

382.60

nmol/l

3.04

2785

16371

(3021589) Normoblasts [#/volume] in Blood

10428

83679

1.46

154.91

18.4

11.9

0.01

0.00

e9/l

1.28

8483

67978

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

819

3011

2.77

154.17

1.6

1.4

—

(3021901) Oxygen saturation in Capillary blood

1058

4449

2.44

151.20

3.6

2.9

89.82

89.53

0.74

1034

4323

(3022806) Fractional oxyhemoglobin in Capillary blood

681

2289

3.02

151.05

2.1

1.8

89.40

89.44

0.06

671

2256

(3017181) Myelocytes/Leukocytes in Blood

2925

17807

1.73

148.53

5.2

4.3

1.04

0.95

0.97

1305

5409

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

935

3744

2.55

148.35

1.6

1.4

—

(3022313) Gas panel - Capillary blood

1774

9259

1.99

147.47

5.0

3.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

923

3722

2.53

144.26

1.6

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4807

33367

1.55

143.67

4.0

3.2

2.77

2.67

e6/l

0.24

2455

16450

(3005719) IgG [Mass/volume] in Serum or Plasma

2437

14300

1.78

140.18

3.8

2.8

10.17

10.68

g/l

5.09

2298

13177

(4035726) Immunohistochemistry procedure

2831

17336

1.72

140.11

1.5

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3017

18813

1.69

139.58

3.0

2.5

46.70

48.38

u/l

0.06

2573

15872

(3018405) Lactate [Moles/volume] in Arterial blood

1403

6855

2.11

139.56

4.4

3.9

1.41

1.39

mmol/l

0.14

1373

6715

(3023520) Reticulocytes [#/volume] in Blood

3178

20104

1.67

139.17

3.2

2.5

73.22

68.45

e9/l

9.40

2263

14941

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1369

6644

2.12

138.58

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1477

7376

2.06

138.56

2.9

2.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1503

7572

2.05

137.64

4.1

3.3

2072.68

1525.27

u/ml

0.30

1291

6507

(3002179) Metamyelocytes/Leukocytes in Blood

2761

16927

1.71

135.74

5.1

4.1

0.79

0.70

0.97

1220

5137

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

694

2509

2.81

134.73

1.8

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1037

4561

2.33

133.65

1.6

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5124

36598

1.51

132.48

3.8

3.1

1.32

1.21

e6/l

0.37

2780

19755

(3026493) Urate [Moles/volume] in Serum or Plasma

6956

52822

1.45

131.99

3.7

2.8

360.94

348.53

umol/l

16.81

6121

45949

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1616

8501

1.96

130.75

1.8

1.6

14.16

16.16

iu/ml

0.20

196

(3019174) dRVVT (LA screen)

121

13.76

130.42

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1227

5849

2.15

129.90

1.9

1.7

—

(3021440) Promyelocytes/Leukocytes in Blood

2750

17046

1.69

129.34

5.3

4.3

0.13

0.12

0.50

1139

4671

(44806071) Cardiolipin IgM antibody measurement

157

173

9.09

128.33

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

119

13.68

127.88

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

758

2999

2.57

123.07

3.2

2.5

10199.11

6365.68

u/ml

0.15

176

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

668

2493

2.72

121.95

1.8

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1480

7755

1.96

120.82

2.5

2.2

471.75

619.14

ug/l

0.97

1407

7344

(3025159) Blasts/Leukocytes in Blood

2714

17129

1.66

118.37

5.5

4.5

0.23

0.38

0.83

1056

4432

(40758558) Short blood count panel - Blood

7435

58080

1.41

117.17

10.1

6.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1387

7192

1.98

116.60

5.1

3.8

25.09

24.85

mmol/l

2.01

1285

6502

(3004119) Hemoglobin [Mass/volume] in Venous blood

2231

13430

1.73

116.05

4.0

3.2

126.66

128.20

g/l

2.50

2178

13039

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1737

9740

1.84

115.03

6.4

4.7

1.61

1.60

0.22

1642

9253

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10511

87201

1.38

115.01

3.8

3.1

168.49

140.42

ug/l

8.88

9790

80454

(3007930) Methemoglobin/Hemoglobin.total in Blood

1614

8882

1.87

113.40

6.6

5.0

0.86

0.87

0.85

1527

8410

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1377

7209

1.96

112.48

1.4

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3116

20604

1.59

111.87

4.8

3.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

632

2404

2.66

111.08

1.8

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

632

2404

2.66

111.08

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

632

2404

2.66

111.08

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

632

2404

2.66

111.08

1.8

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

797

3393

2.39

110.40

3.6

1.51

1.60

0.30

712

3017

(3028026) IgM [Mass/volume] in Serum or Plasma

1918

11217

1.77

110.19

2.4

1.9

1.27

1.35

g/l

0.61

1783

10239

(46235355) HIV 1 and 2 tests - Meaningful Use set

3616

24837

1.54

109.47

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

705

2850

2.51

109.33

7.0

6.1

11.95

12.17

mg/l

0.62

651

2613

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5611

42088

1.44

109.24

4.4

3.0

2.48

2.46

mmol/l

18.57

5035

37554

(3020891) Body temperature

1752

10007

1.81

109.00

5.3

4.4

36.94

36.90

°c

4.02

1733

9912

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2582

16435

1.64

108.20

5.9

3.8

1.22

1.23

mmol/l

1.42

2355

14027

(3047181) Lactate [Moles/volume] in Blood

1211

6212

1.99

104.72

7.4

5.6

1.29

1.34

mmol/l

1.04

1076

5507

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1115

5629

2.02

100.78

1.9

1.6

1.22

1.19

g/l

1.88

1061

5370

(3017143) Hepatitis C virus Ab [Presence] in Serum

2746

18028

1.59

100.78

1.7

1.6

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

15625

139640

1.39

100.18

6.0

4.5

16.11

13.14

mm/h

82.96

14714

129867

(3021601) Nitrite [Presence] in Urine by Test strip

11886

101815

1.35

99.78

5.4

4.1

0.00

estimate

5.34

2917

21119

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

936

4445

2.14

99.62

4.1

3.3

2381.13

685.96

u/ml

2.06

838

4030

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1089

5476

2.03

99.49

1.9

1.6

0.25

0.23

g/l

4.16

1030

5201

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1782

10498

1.75

99.37

2.0

1.6

1.69

1.56

g/l

6.74

1561

8960

(3037522) Nuclear Ab [Titer] in Serum

3617

25369

1.50

98.01

1.4

1.3

550.20

519.88

titre

0.43

792

5622

(3035350) Ketones [Presence] in Urine by Test strip

11997

103115

1.35

97.33

5.5

4.1

6.48

3.91

estimate

0.80

3033

21747

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

446

1512

2.98

97.32

1.7

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

1124

5773

1.99

96.70

4.8

4.2

3.89

mmol/l

0.09

1114

5717

(3009261) Glucose [Presence] in Urine by Test strip

12062

103831

1.34

96.47

5.5

4.2

0.38

0.35

estimate

0.03

2861

20443

(3015736) pH of Urine

9857

82386

1.34

95.86

4.7

3.7

6.24

0.00

5496

45067

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1103

5681

1.98

94.09

1.8

1.4

15.49

16.26

iu/ml

0.06

118

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1025

5166

2.02

92.95

2.8

2.2

127.91

128.16

g/l

0.11

825

3909

(3027273) Bicarbonate [Moles/volume] in Venous blood

1683

9944

1.74

92.62

4.6

3.4

25.38

25.20

mmol/l

1.24

1626

9645

(3003434) Protein [Mass/volume] in Pleural fluid

716

3181

2.28

89.75

1.4

1.5

75.85

31.99

g/l

0.53

656

2874

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1564

9136

1.76

89.50

2.8

2.3

3.80

3.72

g/l

0.98

1438

8243

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1566

9155

1.76

89.36

2.8

2.3

4.23

4.20

g/l

0.61

1442

8262

(3034860) Kappa light chains.free [Mass/volume] in Serum

1386

7819

1.82

89.26

4.6

3.2

59.45

65.08

mg/l

0.26

1144

6622

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1567

9169

1.75

89.13

2.8

2.3

7.48

7.43

g/l

0.55

1440

8264

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1384

7810

1.81

89.04

4.6

3.2

49.11

45.27

mg/l

0.17

1140

6616

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1268

6986

1.86

88.13

4.3

3.1

7.38

5.61

ratio

0.26

695

4070

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3172

22095

1.50

87.91

1.7

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

441

1582

2.81

86.79

1.8

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1423

8189

1.78

85.63

2.5

2.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

874

4298

2.07

84.69

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

874

4298

2.07

84.69

1.4

1.3

—

(3039000) Anion gap in Blood by calculation

869

4265

2.07

84.66

8.5

6.5

11.19

11.30

mmol/l

0.45

784

3838

(3018572) Chloride [Moles/volume] in Blood

869

4266

2.07

84.60

8.5

6.5

105.27

104.96

mmol/l

1.17

784

3840

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1198

6575

1.86

84.21

2.6

2.3

0.02

0.03

g/l

0.26

1065

5871

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1783

10978

1.67

83.96

5.0

4.0

47.86

46.96

0.81

1755

10831

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1374

7871

1.79

83.93

3.0

2.4

1.13

0.91

g/l

0.89

1171

6658

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2706

18404

1.53

83.68

2.6

2.4

6.70

7.24

ug/l

0.49

2307

15919

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1471

8608

1.75

83.47

2.8

2.3

3.01

2.91

g/l

3.71

1347

7700

(3023199) Leukocytes [#/volume] in Pleural fluid

636

2786

2.31

82.38

1.4

1.5

2078.41

2861.47

e6/l

0.89

438

1965

(3045788) Cell count panel - Pleural fluid

543

2219

2.47

82.20

1.4

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1370

7916

1.77

81.18

2.8

2.3

9.99

10.22

g/l

1.09

1227

6931

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

361

1210

3.00

80.41

1.4

13.55

13.43

umol/l

0.11

344

1130

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1309

7548

1.77

78.04

2.2

1.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1139

6341

1.83

76.34

2.7

2.4

0.00

g/l

1.63

986

5530

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

857

4351

2.00

75.95

1.8

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2415

16369

1.53

75.32

4.5

3.8

101.60

92.31

ng/l

4.34

2088

13950

(3036782) Glucose [Moles/volume] in Pleural fluid

515

2159

2.41

73.73

1.3

1.4

6.09

6.32

mmol/l

0.98

475

2013

(3000494) Fungus identified in Specimen by Culture

3214

23229

1.44

72.38

1.7

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

572

2535

2.28

72.07

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

855

4428

1.96

71.53

2.7

2.6

31.38

33.59

umol/l

2.04

777

3931

(3042631) Mycobacterium sp identified in Specimen

608

2789

2.20

70.47

2.6

2.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

334

1158

2.90

70.06

1.8

1.4

—

(40761536) Microorganisms panel - Urine sediment

2227

15059

1.52

69.91

5.8

4.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

560

2498

2.26

69.48

1.4

55385.65

56731.91

e6/l

0.04

306

1431

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

324

1115

2.92

68.90

1.8

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1053

5930

1.81

67.82

2.7

2.4

0.00

g/l

-0.00

985

5515

(3019309) Folate [Moles/volume] in Red Blood Cells

4866

38096

1.35

67.26

1.9

1.8

1156.51

1157.69

nmol/l

0.03

3759

28603

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1473

9131

1.65

67.03

6.1

3.6

104.43

66.14

u/ml

1.94

1427

8801

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

469

1975

2.39

66.49

2.0

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1271

7599

1.71

66.37

2.1

1.7

10.83

7.22

iu/ml

1.72

283

1796

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

19094

179760

1.42

66.27

32.8

17.5

28.08

25.83

mg/l

18.35

17947

150411

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

349

1278

2.75

66.11

1.8

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

7308

60744

1.30

65.47

1.9

1.7

19.26

20.25

nmol/l

6.80

6374

51271

(3023419) Bacteria identified in Sputum by Culture

575

2666

2.18

64.88

2.8

2.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

443

1853

2.41

63.76

2.0

1.7

—

(3017732) Neutrophils [#/volume] in Blood

3261

24127

1.41

63.60

4.2

3.2

4.71

4.64

e9/l

0.14

2803

20457

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1016

5800

1.78

62.44

3.6

2.8

1.81

1.64

mg/l

6.56

936

5209

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

410

1673

2.47

62.31

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

410

1673

2.47

62.31

1.9

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

410

1673

2.47

62.31

1.9

1.6

—

(40768806) Pleura Pathology biopsy report

526

2394

2.22

62.16

1.5

—

(3017569) Oxygen content in Arterial blood

322

1169

2.77

62.03

2.4

2.2

15.73

15.80

0.14

322

1169

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13276

119523

1.26

59.23

4.3

3.3

61.95

51.68

u/l

18.87

12515

111205

(3017354) Segmented neutrophils/Leukocytes in Blood

495

2242

2.23

59.20

3.9

3.6

61.13

57.59

3.25

431

1906

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

618

3055

2.04

58.93

1.3

1.2

279.62

277.66

u/ml

0.06

412

1894

(3037121) Protein [Mass/volume] in Urine

1140

6835

1.70

58.77

4.3

3.1

897.16

482.46

mg/l

0.81

618

2958

(3008757) Leukocyte morphology finding [Identifier] in Blood

462

2040

2.28

58.74

4.3

3.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1811

12157

1.53

58.30

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

6900

57647

1.28

57.36

5.7

4.3

0.00

estimate

0.01

2665

19185

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

897

5078

1.79

56.65

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

644

3281

1.98

56.43

1.3

1.2

45.12

52.09

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

667

3444

1.96

56.23

1.6

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

478

2183

2.21

56.03

1.3

434.98

473.93

u/l

0.25

446

2075

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

361

1465

2.48

55.55

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

921

5298

1.76

55.05

3.3

2.9

61.03

60.82

0.10

886

5091

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

608

3069

2.00

54.71

1.6

1.4

156.15

153.79

au/ml

0.17

165

901

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10034

87994

1.25

54.04

2.8

2.4

76.57

1121.06

nmol/l

0.50

9079

78674

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

261

913

2.87

53.96

1.8

2.0

103.00

95.66

2.19

237

866

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

559

2759

2.04

53.54

1.9

22.03

25.50

ug/l

0.91

551

2690

(3048929) Epstein Barr virus Ab [Presence] in Serum

808

4509

1.81

53.51

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

846

4790

1.79

53.38

1.9

1.6

—

(3025941) Bacteria identified in Stool by Culture

1488

9754

1.56

53.23

1.4

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

653

3429

1.92

52.37

1.5

1.4

30.53

21.34

u/ml

—

(3011412) CD3 cells [#/volume] in Blood

376

1604

2.36

51.83

2.3

1394.69

1147.83

e6/l

0.47

344

1433

(3007164) IgA [Mass/volume] in Serum or Plasma

4378

34899

1.31

51.16

1.9

1.5

2.57

2.54

g/l

0.32

2834

20785

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

306

1204

2.55

50.31

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

487

2346

2.09

49.82

1.6

1.5

27.96

28.76

ng/l

0.11

487

2340

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

471

2243

2.11

49.66

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

298

1169

2.56

49.31

2.2

2.0

7.87

8.16

mmol/l

0.73

298

1169

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1252

8054

1.58

48.53

2.0

1.9

38.35

39.24

u/l

0.75

1100

7042

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

166

5.54

48.16

1.2

0.82

0.06

u/ml

1.24

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

382

1710

2.25

47.07

1.3

11.48

14.41

u/l

1.93

348

1573

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

605

3214

1.90

46.85

1.8

1.4

16.82

13.71

u/ml

0.27

(3020876) Protein [Mass/time] in 24 hour Urine

529

2686

1.98

46.83

2.9

2.4

1.15

1.16

g/24h

0.02

358

1520

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2096

15143

1.42

45.75

1.6

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

296

1202

2.47

45.56

2.0

1.9

15.05

16.11

0.85

287

1168

(3003129) Base excess in Capillary blood by calculation

487

2426

2.02

45.50

2.7

2.3

0.57

0.51

mmol/l

0.11

469

2339

(3013512) EKG study

8088

70185

1.23

45.08

4.7

3.9

0.53

0.75

0.86

190

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

259

993

2.62

44.95

2.2

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

259

993

2.62

44.95

2.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

259

993

2.62

44.95

2.2

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

359

1598

2.26

44.87

1.5

1.4

12.07

13.29

u/l

2.39

344

1542

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

259

994

2.61

44.86

2.2

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6311

53344

1.25

44.76

5.0

3.6

0.47

0.26

estimate

0.48

2396

16600

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

402

1881

2.15

44.40

3.1

2.8

—

(3052851) Hemolysis interference index of Serum or Plasma

940

5767

1.65

44.22

4.1

3.4

2.03

2.07

index

0.07

508

2899

(3005322) IgE [Units/volume] in Serum or Plasma

1589

10969

1.48

44.21

1.5

1.3

204.36

242.70

u/ml

0.93

1486

10143

(1175426) CD3 cells/Lymphocytes in Blood

303

1265

2.40

43.92

2.0

72.55

72.18

0.14

293

1204

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10296

91754

1.22

43.75

2.4

2.2

93.15

95.53

pmol/l

5.90

6022

48507

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8732

76606

1.22

43.17

5.6

4.2

0.89

0.52

estimate

0.42

2441

17186

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

207

724

2.86

42.91

1.5

1.9

197.87

158.67

6.06

191

680

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

205

717

2.86

42.50

2.4

1.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

931

5756

1.64

42.47

1.6

1.5

0.30

8.76

iu/ml

1.84

190

1154

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

203

708

2.87

42.31

2.4

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

203

708

2.87

42.31

2.4

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

5712

48024

1.25

41.89

4.9

4.0

0.10

0.27

0.92

533

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

936

5815

1.63

41.87

1.5

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

133

362

3.67

41.63

1.5

1.2

199.89

27.56

mg/l

1.47

265

(3042111) Morphology [Interpretation] in Bone marrow Narrative

628

3504

1.81

41.61

1.8

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

206

731

2.82

41.59

44.4

38.8

7.15

7.27

ug/l

0.36

189

645

(3024980) IgG subclass 4 [Mass/volume] in Serum

566

3059

1.86

41.57

1.6

0.76

0.80

g/l

0.33

437

2361

(3037692) Legionella sp identified in Specimen by Organism specific culture

193

662

2.92

41.48

1.5

1.4

—

(3035880) pH of Pleural fluid

284

1184

2.41

41.32

1.3

7.40

0.00

200

845

(21494815) CD4 cells/Lymphocytes in Specimen

325

1441

2.26

41.04

2.0

2.1

37.96

38.54

0.25

316

1413

(3044889) 12 lead EKG panel

14285

131909

1.22

40.99

5.2

4.4

0.48

2537.57

1.18

301

(40768797) Stomach Pathology biopsy report

3461

27442

1.30

40.92

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

304

1318

2.31

40.48

1.2

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

662

3787

1.76

40.31

1.4

1.2

268.25

289.15

titre

0.10

287

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

664

3804

1.76

40.22

1.4

1.2

225.00

120.26

titre

0.37

(3014051) Protein [Presence] in Urine by Test strip

6292

53658

1.23

40.11

4.0

3.1

0.10

0.08

0.15

188

1491

(3022145) Colonoscopy Study observation

2894

22473

1.32

39.69

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

306

1345

2.28

39.47

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

188

654

2.88

39.41

1.7

1.9

12855.68

37999.65

u/ml

0.65

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

163

527

3.09

38.89

1.4

2.0

222.13

182.12

3.43

156

502

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2302

17352

1.36

38.51

3.4

2.5

0.55

0.44

e6/l

0.80

2226

16659

(3010375) cycloSPORINE [Mass/volume] in Blood

197

712

2.77

38.46

36.3

28.7

112.22

110.42

ug/l

0.16

167

584

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

307

1367

2.25

38.40

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

312

1400

2.24

38.31

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

312

1403

2.23

38.12

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1648

2.13

38.10

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

469

2476

1.90

37.07

20.5

7.1

7.13

7.60

mmol/l

1.98

412

2044

(3000012) Reticulocyte production index

575

3242

1.79

36.81

2.7

2.1

0.99

0.89

3.56

436

2204

(40759836) Histone Ab [Presence] in Serum by Immunoblot

314

1438

2.19

36.69

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

977

6328

1.56

36.63

1.5

1.4

261.44

266.03

ug/g

0.27

584

3758

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

317

1463

2.17

36.34

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

267

1148

2.33

36.29

1.2

86.67

82.17

0.85

(3010503) CD19 cells [#/volume] in Blood

252

1059

2.38

36.09

2.4

2.5

231.48

366.50

e6/l

0.43

245

1017

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

148

474

3.12

35.92

1.1

88.27

86.86

0.17

232

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

345

1655

2.09

35.80

2.4

1.7

4.08

4.18

mg/l

0.17

331

1579

(3003694) ABO and Rh group [Type] in Blood

5918

50633

1.22

35.61

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

522

2888

1.82

35.60

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

376

1884

2.00

34.66

1.4

6.58

6.87

g/l

0.75

271

1352

(3024139) IgG subclass 3 [Mass/volume] in Serum

375

1883

2.00

34.36

1.4

0.39

0.44

g/l

1.70

270

1353

(3024891) Influenza virus A+B Ag [Presence] in Specimen

736

4529

1.64

34.20

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

218

881

2.48

34.04

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

374

1885

1.99

33.92

1.4

2.83

2.94

g/l

0.53

272

1354

(4062490) Immunoglobulin typing, IgG

368

1845

2.00

33.88

1.4

—

(3019225) pH of Specimen

2550

19901

1.31

33.30

6.5

4.2

7.36

0.24

2055

14084

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

661

2.69

33.06

3.0

9.47

10.34

kpa

4.50

178

661

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

661

2.69

33.06

3.0

4.96

4.95

kpa

0.01

178

661

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2105

16019

1.34

32.79

3.8

2.7

60.59

63.32

ml/min/173m2

2.03

1019

6873

(3008536) Aspergillus sp Ab [Presence] in Serum

123

373

3.30

32.71

2.6

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

333

1636

2.04

32.45

2.5

2.4

30.02

25.35

iu/ml

0.30

201

(3000492) Spirometry study

2240

17237

1.33

32.29

1.6

1.5

—

17.22

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

402

2116

1.91

32.12

3.8

3.7

—

(3045142) Bone marrow Pathology biopsy report

429

2307

1.87

32.09

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

803

5130

1.58

31.96

2.1

2.0

12.34

11.92

mg/l

0.62

738

4765

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

394

2079

1.90

31.26

1.3

1.2

—

(3004451) EKG impression Narrative

267

1227

2.18

31.01

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

423

2290

1.86

30.99

3.5

9.81

11.73

nmol/l

0.19

407

2222

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1036

7069

1.48

30.36

1.3

1.2

0.72

1.03

u/ml

0.58

593

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

234

1036

2.26

29.80

2.5

2.8

38.46

38.71

0.06

131

584

(3000475) Leukocytes [#/volume] in Synovial fluid

811

5279

1.55

29.73

1.8

1.6

14644.51

14530.72

e6/l

0.02

554

3722

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

368

1932

1.91

29.67

5.1

4.0

93.84

61.75

u/ml

1.21

363

1899

(3042733) HLA Ab [Presence] in Serum

145

513

2.83

29.59

4.8

5.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

247

1123

2.20

29.49

2.6

2.5

226.55

237.86

e6/l

0.36

215

978

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

498

2879

1.74

29.30

2.7

2.1

32.20

32.51

0.78

490

2861

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

604

3683

1.65

29.13

1.5

1.4

309.91

172.80

pmol/l

2.26

591

3591

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

461

2635

1.76

28.24

2.6

2.7

134.39

914.01

u/ml

1.36

455

2601

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

779

5087

1.54

28.15

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

288

1415

2.04

28.13

1.5

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

110

343

3.20

28.03

1.2

114.65

106.74

1.01

101

330

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

227

1021

2.23

27.86

3.5

3.9

—

(40762365) Oxygen content in Arterial blood by calculation

102

306

3.33

27.68

2.9

2.7

14.97

14.92

ml/dl

0.05

282

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

136

486

2.80

27.29

1.2

103.47

105.26

0.19

126

446

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

218

975

2.24

27.14

1.2

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

291

1457

2.00

26.99

1.2

110.00

135.20

titre

0.25

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

291

1459

2.00

26.89

1.2

208.14

168.88

titre

0.38

242

(3034770) Mitochondria Ab [Titer] in Serum

783

5191

1.52

26.40

1.2

1246.67

839.21

titre

0.75

151

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

727

4743

1.54

26.39

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

280

1395

2.01

26.35

1.5

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

234

1097

2.14

25.93

2.4

697.40

512.31

e6/l

0.59

192

898

(3024932) HLA-DR beta [Type]

132

481

2.74

25.55

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

401

2277

1.77

25.18

2.7

2.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

834

5657

1.49

25.18

1.6

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

129

469

2.75

25.09

1.1

1.2

84.12

85.89

0.17

233

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

728

4805

1.53

25.07

1.3

1.2

11.53

13.09

u/ml

0.07

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

241

1160

2.08

24.95

2.4

2.5

0.87

0.66

e9/l

0.50

226

1097

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

777

5218

1.50

24.64

1.3

7.30

6.38

u/ml

0.20

125

776

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

608

3871

1.58

24.61

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4994

43288

1.19

24.35

1.8

22913051.06

28564202.97

pmol/l

0.30

4120

35412

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

777

5231

1.50

24.35

1.3

6.65

4.80

u/ml

0.20

508

(3024471) HLA-A [Type]

132

496

2.66

24.10

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

579

3668

1.59

23.95

1.3

50.16

32.93

u/l

1.44

509

3148

(3045414) Leukocytes [Presence] in Urine

2424

19560

1.26

23.83

2.6

2.1

0.00

0.02

estimate

6.59

437

3764

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

321

3.08

23.70

1.1

1.2

95.60

76.50

3.09

104

(3014765) Yersinia sp identified in Stool by Organism specific culture

761

5130

1.49

23.70

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

19211

185503

1.23

23.60

36.7

21.1

139.48

139.63

mmol/l

13.20

19019

181812

(42529406) Shigella sp [Presence] in Stool by Culture

762

5143

1.49

23.59

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

175

758

2.31

23.58

14.9

14.0

901.82

2544.84

nmol/l

0.47

170

726

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

487

2979

1.64

23.27

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3949

33626

1.21

23.25

1.4

1.3

39.88

36.62

iu/ml

0.25

1197

10297

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.41

23.14

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

194

886

2.19

23.03

3.3

3.4

1.39

1.32

0.21

194

886

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1508

11494

1.33

22.96

3.3

3.4

4.32

4.43

pmol/l

4.52

1341

10227

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

179

797

2.25

22.62

19.7

19.0

1487.58

2597.68

nmol/l

0.45

172

768

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

750

5094

1.48

22.51

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

812

5602

1.46

22.50

1.3

46.48

41.88

u/ml

0.14

291

(40768446) Kidney Pathology biopsy report

160

681

2.35

22.47

1.8

1.6

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

439

2644

1.67

22.31

1.2

19.77

7.85

u/ml

0.33

104

(3005532) Lymphocytes/Leukocytes in Pleural fluid

175

778

2.25

22.21

1.4

64.12

64.67

0.07

138

643

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

252

1288

1.96

22.14

1.6

1.3

2.17

1.33

u/ml

0.78

153

758

(3001893) Eosinophils/Leukocytes in Pleural fluid

155

657

2.36

21.99

1.4

1.5

2.48

2.55

0.04

130

553

(3008037) Lactate [Moles/volume] in Venous blood

786

5416

1.46

21.93

4.1

3.3

1.55

1.60

mmol/l

0.87

767

5284

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

488

3032

1.62

21.93

4.8

3.6

49.58

37.90

u/ml

1.07

473

2935

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

249

3.29

21.92

2.2

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

673

4499

1.50

21.85

1.3

1.2

5.40

4.23

u/ml

0.17

297

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

130

510

2.55

21.81

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

322

2.98

21.72

1.1

1.2

81.41

69.42

1.48

100

(3023103) Potassium [Moles/volume] in Serum or Plasma

19217

185825

1.22

21.71

37.1

21.3

4.00

3.99

mmol/l

13.48

19019

181870

(3022493) Free Hemoglobin [Mass/volume] in Plasma

188

870

2.16

21.63

3.4

3.8

827.62

1076.12

mg/l

0.11

145

597

(40768441) Liver Pathology biopsy report

261

1363

1.92

21.53

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

760

5244

1.46

21.06

1.2

95.47

136.34

titre

1.43

495

(3048689) Calprotectin [Mass/mass] in Stool

2725

22572

1.23

20.99

2.6

2.3

174.14

144.43

ug/g

3.37

2233

17749

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2348

19145

1.25

20.93

2.0

1.8

1.57

1.50

3.52

1995

16519

(3023383) Lactate [Moles/volume] in Pleural fluid

156

681

2.29

20.71

1.3

3.59

3.41

mmol/l

0.31

140

628

(3013727) Leukocytes other/Leukocytes in Blood

140

583

2.40

20.70

3.5

3.6

57.72

53.08

1.86

134

563

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

323

1830

1.77

20.54

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

211

1047

2.02

20.21

2.4

2.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

172

790

2.18

20.20

15.1

13.6

0.65

0.63

mmol/l

0.70

161

722

(3009214) Lutropin [Units/volume] in Serum or Plasma

595

3942

1.52

20.19

1.5

1.4

12.93

10.91

u/l

2.39

495

3171

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

200

975

2.05

20.12

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

200

975

2.05

20.12

1.6

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

804

11153

0.71

20.05

1.7

3.47

3.46

mmol/l

0.12

552

7833

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

233

3.25

20.04

1.3

1.4

65.04

75.59

1.93

193

(3025468) Yersinia sp identified in Specimen by Organism specific culture

404

2450

1.65

20.04

1.7

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

516

3324

1.56

19.92

2.5

2.1

5412.39

4691.75

u/l

0.21

185

1257

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

267

1442

1.85

19.90

1.3

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

671

4570

1.48

19.90

4.4

3.4

7.44

7.68

mmol/l

1.56

654

4461

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

317

2.90

19.88

1.3

5900.00

3664.55

u/ml

0.16

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1182

15402

0.75

19.69

2.0

3.56

3.47

ratio

1.64

936

12136

(3021162) Amylase [Enzymatic activity/volume] in Specimen

330

2.84

19.64

2.6

2.8

1218.68

1698.01

u/l

0.24

298

(3005988) Vibrio sp identified in Specimen by Organism specific culture

404

2464

1.64

19.61

1.7

1.4

—

(3002256) Pathology report gross observation

3121

26376

1.21

19.55

1.4

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

222

1136

1.95

19.50

2.3

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

403

2462

1.64

19.44

1.7

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

321

1847

1.74

19.37

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

1129

8466

1.35

19.18

2.6

2.8

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

241

3.15

18.99

6.7

5.5

56.94

43.87

ug/min

0.85

189

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

424

2639

1.61

18.98

1.7

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

202

1011

2.00

18.93

2.5

2.1

17.60

27.46

umol/l

0.82

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3637

31253

1.19

18.92

1.4

1.3

15.55

12.63

u/ml

0.62

1316

11716

(3024522) Salmonella sp identified in Specimen by Organism specific culture

417

2589

1.61

18.86

1.7

1.4

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

120

488

2.46

18.73

1.4

26.77

21.32

1.11

409

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

182

881

2.07

18.70

1.7

1.8

109.02

117.68

umol/l

0.12

447

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

118

477

2.47

18.66

9.6

5.9

70.30

69.79

0.08

359

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

414

2577

1.61

18.54

1.7

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

148

663

2.23

18.53

1.3

1.2

0.55

0.34

g/l

—

(3006245) CD3-CD19+ cells/cells in Blood

134

577

2.32

18.43

2.0

9.80

9.87

0.02

120

532

(3014148) Varicella zoster virus Ab [Titer] in Serum

334

1988

1.68

17.86

1.2

1.1

—

(4281824) Cell count and differential, peritoneal fluid

345

2076

1.66

17.70

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

244

1333

1.83

17.60

2.2

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

147

674

2.18

17.42

5.6

6.4

25.00

25.02

mmol/l

0.02

138

605

(3006571) Granulocytes/Leukocytes in Synovial fluid

397

2494

1.60

17.15

1.6

1.5

58.72

59.89

0.22

240

1557

(1761868) Lipid panel - Serum or Plasma

5853

64330

0.87

17.13

3.5

3.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

131

580

2.26

16.92

2.0

30.89

29.66

0.34

123

547

(3001964) Herpes simplex virus Ag [Presence] in Specimen

115

483

2.38

16.78

1.7

1.4

—

(3012565) Volume of 24 hour Urine

186

946

1.97

16.71

2.5

2.2

1834.56

1927.14

0.63

172

825

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

201

1050

1.91

16.70

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

201

1050

1.91

16.70

1.4

1.5

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

133

598

2.22

16.57

1.4

21.32

20.11

0.19

121

536

(3051651) Icteric interference index of Serum or Plasma

213

1141

1.87

16.39

5.0

3.7

0.75

0.94

index

2.78

206

1115

(3009466) Valproate [Moles/volume] in Serum or Plasma

406

2601

1.56

16.15

5.8

4.9

345.36

352.05

umol/l

0.42

349

2234

(3028707) Methadone [Presence] in Urine by Screen method

303

1807

1.68

16.13

3.1

2.7

—

(40757373) Influenza virus identified in Isolate

385

2.51

16.02

1.7

1.5

—

(21494434) Karyotype in Bone marrow

301

1796

1.68

16.00

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

244

1379

1.77

15.78

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

14804

141230

1.13

15.75

4.9

4.4

15.03

14.92

pmol/l

6.07

13645

128578

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

216

1178

1.83

15.73

1.1

—

0.57

—

(3003181) Sodium [Moles/volume] in Urine

609

4263

1.43

15.72

1.4

61.79

60.91

mmol/l

0.21

461

3424

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

218

3.02

15.47

1.2

1.3

91.49

104.44

ug/l

0.29

140

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

113

3.88

15.21

1.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

15336

146761

1.13

15.11

38.1

21.6

14.28

13.75

304.28

15206

144796

(3047189) Immunofixation for 24 hour Urine

188

995

1.89

15.06

2.0

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

330

2055

1.61

14.85

1.2

27.61

42.53

u/ml

0.66

118

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

301

2.65

14.77

1.3

1.2

535.59

159.11

u/l

0.41

211

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

273

2.74

14.76

3.3

2.6

83.93

54.04

mg/l

—

(3014271) Vancomycin [Susceptibility]

211

1166

1.81

14.75

3.3

3.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

371

2.47

14.73

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

355

2260

1.57

14.57

1.4

280.77

276.58

mosm/kgh2o

2.42

275

1690

(21494755) Public health laboratory ask at order entry panel

957

12322

0.76

14.54

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7164

77154

0.89

14.53

2.0

1.9

1.47

1.34

mmol/l

19.09

5946

63994

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.07

14.44

10.5

11.4

103.33

107.44

g/l

0.79

(3035947) Staphylolysin Ab [Units/volume] in Serum

180

953

1.89

14.43

1.1

5.81

4.17

iu/ml

0.38

(44816559) Phosphatidylethanol [Mass/volume] in Blood

915

6960

1.32

14.14

1.8

1.7

0.34

0.31

mg/l

0.67

434

3277

(3000330) Specific gravity of Urine by Test strip

1320

10534

1.26

14.07

4.7

3.6

1.02

ratio

1.07

1198

9531

(3042010) Triglyceride [Moles/volume] in Pleural fluid

339

2.50

13.96

1.3

1.2

1.11

1.37

mmol/l

0.20

212

(3003329) Lymphocytes/Leukocytes in Synovial fluid

302

1875

1.61

13.80

1.6

1.5

30.01

28.79

0.22

181

1131

(3039162) Centromere protein B Ab [Units/volume] in Serum

356

2298

1.55

13.77

1.3

51.86

59.27

u/ml

0.20

149

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

598

4278

1.40

13.71

1.2

3.30

3.70

0.60

494

(3011288) Drugs identified in Urine by Screen method Nominal

418

2798

1.50

13.65

4.4

2.9

—

(3046861) Legionella sp Ag [Presence] in Urine

118

3.63

13.56

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

325

2063

1.58

13.54

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4491

40155

1.14

13.35

1.3

1.40

1.69

u/ml

1.18

1187

10528

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

384

2546

1.51

13.15

1.1

1.53

g/l

0.00

357

2321

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

574

4115

1.40

13.02

1.6

1.4

1415.04

2031.32

e6/l

0.37

468

3274

(3045424) Erythrocytes [Presence] in Urine

1238

9905

1.26

12.92

2.7

2.1

0.00

0.13

estimate

0.83

323

2887

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

567

4063

1.40

12.90

1.5

1.3

27.55

30.98

e6/l

0.12

437

3028

(3019150) Specific gravity of Urine by Refractometry

5047

45556

1.13

12.89

5.7

4.4

1.02

1.15

kg/l

1.35

3666

30460

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

441

3031

1.46

12.64

1.1

1.2

1.62

0.90

—

(3010838) Calcium [Moles/time] in 24 hour Urine

497

3496

1.42

12.58

1.8

1.9

4.62

4.95

mmol/24h

1.35

433

3068

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

327

2.44

12.52

1.4

1.5

11.83

12.21

0.04

165

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

559

4017

1.40

12.52

1.3

1.2

45.74

47.75

u/ml

0.10

375

(43055442) Apixaban [Mass/volume] in Serum or Plasma

408

2.27

12.42

1.6

101.21

116.12

ug/l

0.77

337

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

289

4441

0.64

12.40

1.1

0.66

0.63

ratio

0.39

660

(3000060) B lymphocytes [#/volume] in Blood

396

2.29

12.38

1.9

2.0

0.12

0.66

e9/l

1.52

193

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

110

518

2.12

12.34

1.1

1.2

8.17

13.77

pmol/l

2.22

182

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

271

1689

1.60

12.25

2.1

10.27

1.77

u/field

0.53

160

911

(3017704) Immunofixation for Urine

203

1176

1.72

12.17

1.9

1.5

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

231

1386

1.67

12.16

3.9

3.5

154.60

170.05

nmol/l

0.18

226

1368

(3051611) Lipemic interference index of Serum or Plasma

320

2077

1.54

12.14

4.7

3.5

13.88

13.15

index

0.57

206

1117

(3009508) Creatinine [Moles/volume] in Urine

7587

70322

1.11

12.09

3.8

3.4

7.35

7.32

mmol/l

0.19

6358

58841

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

182

1024

1.78

12.08

1.8

1.9

2.92

2.68

u/field

0.16

131

710

(3020682) Albumin/Creatinine [Ratio] in Urine

7475

69258

1.11

11.96

4.6

4.2

11.15

8.64

mg/mmol

4.29

4772

43012

(3004716) Salmonella sp identified in Stool by Organism specific culture

975

7663

1.28

11.82

1.3

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

239

1458

1.64

11.81

1.6

1.4

1.13

1.19

promille

0.24

193

1144

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

322

2107

1.53

11.79

1.9

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

136

704

1.93

11.77

2.7

2.6

0.60

0.61

mmol/l

0.72

136

704

(3023511) Choriogonadotropin [Units/volume] in Urine

243

1491

1.63

11.73

1.4

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

276

1747

1.58

11.72

1.2

76.23

82.80

u/ml

0.11

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.56

11.54

3.7

4.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

631

4689

1.35

11.50

1.4

1.3

557.37

556.15

mg/l

0.02

612

4473

(3004616) Nuclear Ab [Presence] in Serum

361

2436

1.48

11.42

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

436

2.17

11.41

2.2

2.5

126.74

540.62

ug/l

0.82

436

(37208534) Antinuclear antibody arbitrary concentration in serum

114

563

2.02

11.31

1.1

—

(3014891) Appearance of Pleural fluid

319

2.38

11.27

1.6

1.5

—

(40768795) Lymph node Pathology biopsy report

305

1993

1.53

11.26

1.3

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

322

2129

1.51

11.25

2.0

2.2

1.43

6.31

titre

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

288

1864

1.55

11.11

1.2

1.1

2.14

2.12

iu/ml

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

143

769

1.86

11.05

1.7

2.0

2292.55

2563.79

e6/l

0.06

524

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

366

2.26

11.00

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

327

2183

1.50

10.93

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

173

2.88

10.92

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

574

4240

1.36

10.90

1.9

1.8

325.12

287.89

mu/l

1.66

524

3869

(4015189) Microbial culture of sputum

106

517

2.05

10.90

2.7

2.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

17821

173091

1.13

10.88

30.0

17.4

75.86

77.01

ml/min/173m2

10.29

16984

161089

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

270

2.47

10.87

1.4

1.2

152.46

422.31

ng/l

0.42

177

(3009871) Measles virus Ab [Titer] in Serum

122

627

1.94

10.83

1.6

3338.18

3326.55

titre

0.01

110

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17648

179731

0.89

10.76

6.1

2.61

2.63

mmol/l

2.29

16255

166105

(3042951) Complement C1q Ab [Units/volume] in Serum

4.07

10.76

1.1

1.2

32.20

18.17

u/ml

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

209

2.67

10.62

10.3

7.5

0.44

0.43

umol/l

0.03

188

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.65

10.56

5.0

4.8

—

(3038026) Centromere Ab [Units/volume] in Serum

238

1494

1.59

10.52

1.3

1.2

40.00

54.43

u/ml

—

(4198724) Urine methamphetamine measurement

101

492

2.05

10.44

2.2

2.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

104

513

2.02

10.39

1.6

0.36

0.39

ug/l

0.26

345

(4024509) Urine culture

1160

9449

1.23

10.34

2.3

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17188

175220

0.89

10.31

5.4

5.2

1.40

1.46

mmol/l

63.58

15788

161398

(3003327) Ova and parasites identified in Stool by Light microscopy

793

6186

1.29

10.25

1.7

—

(40768443) Skin Pathology biopsy report

1136

9246

1.24

10.21

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

344

2.23

9.94

6.1

4.5

41.73

68.74

u/l

1.51

333

(3011985) Renin [Units/volume] in Plasma

399

2820

1.42

9.94

1.6

1.4

61.38

59.59

mu/l

0.06

363

2505

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

226

1422

1.59

9.93

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1334

11083

1.21

9.80

1.2

121.18

136.99

u/ml

0.76

434

4067

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17330

176476

0.90

9.78

5.4

5.3

4.51

4.55

mmol/l

4.98

16035

163654

(3041918) Cholesterol [Moles/volume] in Pleural fluid

431

2.08

9.77

1.3

1.2

1.91

1.51

mmol/l

2.29

268

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

556

4163

1.34

9.71

1.3

1.2

3.80

mmol/l

0.01

523

3941

(40761539) Cells [Type] in Urine sediment by Light microscopy

473

2.02

9.66

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

398

2831

1.41

9.58

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.82

9.57

1.3

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

264

1742

1.51

9.40

1.5

1.6

25.11

25.38

u/ml

0.03

341

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

126

689

1.83

9.32

1.2

1.3

405.49

233.26

ug/l

0.40

373

(3012516) Albumin [Mass/volume] in Urine

7267

67862

1.10

9.31

3.9

3.5

62.91

47.74

mg/l

4.82

4822

43296

(3028433) Virus identified in Specimen by Culture

109

570

1.91

9.27

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1231

10205

1.21

9.26

1.7

—

(3016750) Collection duration of Urine

183

1114

1.64

9.24

2.6

2.2

495.90

498.63

min

0.13

133

829

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.86

9.23

1.2

1.0

1.45

1.08

u/field

0.74

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

101

516

1.95

9.20

2.2

1.9

45.93

36.89

u/l

0.22

479

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

280

2.31

9.18

1.4

1.3

46.34

41.87

mg/l

0.31

234

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

179

2.67

9.17

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

645

4973

1.30

9.16

1.8

1.9

28.86

7.17

iu/l

0.65

251

1928

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

139

788

1.76

9.12

1.4

4656733.33

1712407.94

iu/ml

—

(3044007) Cell count panel - Peritoneal fluid

119

644

1.84

9.11

1.7

1.9

—

(3042517) Benzodiazepines panel - Urine

110

3.17

9.06

3.2

2.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

131

733

1.78

9.00

1.7

1.92

1.97

umol/l

0.28

120

669

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

501

1.95

8.92

3.1

3.0

2.04

1.86

ratio

0.27

454

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

120

656

1.83

8.90

1.7

1.9

21817.27

11475.77

e6/l

0.52

345

(3034891) Synovial lining cells/cells in Synovial fluid

162

968

1.67

8.81

1.5

2.68

3.88

0.76

193

(1761482) Bacteria [#/volume] in Urine by Culture

678

5294

1.28

8.76

5.7

4.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

223

1446

1.54

8.65

1.3

2.25

2.19

mmol/l

0.31

210

1338

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

197

2.53

8.59

3.0

3.1

1.75

1.09

mg/l

0.74

148

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

131

746

1.75

8.50

1.4

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

154

919

1.67

8.44

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

390

2.05

8.35

2.0

1.9

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

270

1837

1.47

8.34

1.7

1.9

3480.00

1964.56

titre

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

378

2.06

8.28

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

284

1955

1.45

8.26

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

393

2.03

8.19

1.3

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

141

830

1.70

8.15

1.6

1.2

48.31

62.95

0.76

(3002619) Bacteria identified in Specimen by Culture

525

1.88

8.13

1.4

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

362

2610

1.39

8.12

1.4

1.3

341.88

340.03

pmol/l

0.01

308

2189

(3022621) pH of Urine by Test strip

1814

15731

1.16

8.09

3.3

2.8

6.02

6.05

0.79

1312

10828

(40763590) HLA-DQ beta [Type]

3.98

7.99

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

220

1449

1.52

7.99

1.3

79.29

56.36

titre

0.41

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

337

2.10

7.97

1.6

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

161

989

1.62

7.91

2.8

2.3

229.35

205.83

u/l

1.31

161

979

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

237

2.31

7.82

1.5

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

165

1023

1.61

7.82

1.1

—

(46236302) HLA-C [Type] by High resolution typing

3.91

7.80

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

224

1490

1.50

7.77

1.3

499.00

534.58

titre

0.05

120

(3023323) Follitropin [Units/volume] in Serum or Plasma

749

6010

1.25

7.75

1.4

30.45

31.21

iu/l

0.25

629

5171

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

313

2222

1.41

7.72

1.2

61.41

60.94

u/l

0.04

292

1930

(3043410) Blood group antigens tested for on Red Blood Cells

102

559

1.82

7.58

2.0

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

180

2.49

7.54

1.1

1.0

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

134

2.75

7.54

1.4

1.3

0.65

1.02

ml/s/173m2

1.72

(3017315) Amylase [Enzymatic activity/volume] in Urine

164

1026

1.60

7.51

1.2

209.71

363.03

u/l

2.38

153

943

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

236

2.28

7.45

4.2

2.9

40.79

40.24

umol/l

0.06

198

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

380

1.99

7.45

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

124

2.81

7.43

2.1

2.3

—

(3032057) Clostridioides difficile [Presence] in Stool

444

1.91

7.35

2.4

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

445

1.90

7.30

7.6

7.5

5.78

5.56

kpa

0.33

445

(3024263) Appearance of Synovial fluid

160

1004

1.59

7.25

1.7

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

360

2647

1.36

7.21

2.4

2.1

29.62

25.43

mg/l

0.79

150

941

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

153

955

1.60

7.10

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

192

2.39

7.06

1.9

1.7

53.83

46.90

umol/l

0.61

192

(3015956) Eosinophils/Leukocytes in Blood by Manual count

268

2.16

7.03

2.3

2.6

2.09

2.54

0.36

263

(40760410) HLA-B [Type] by High resolution

3.74

7.01

1.0

—

(40760409) HLA-A [Type] by High resolution

3.74

7.01

1.0

—

(44786800) Granulocytes/Leukocytes in Body fluid

262

2.17

7.00

1.2

1.3

22.95

24.19

0.10

205

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

315

2280

1.38

6.98

1.1

2.09

2.98

0.96

315

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.59

6.95

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

496

1.83

6.93

1.2

1.4

29.90

40.48

g/l

0.41

379

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

233

1604

1.45

6.86

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

138

849

1.62

6.81

1.1

—

(3013862) HLA-DP [Type]

3.61

6.68

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

348

1.98

6.65

2.1

1.8

1.18

1.19

mmol/l

0.15

332

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

379

2846

1.33

6.64

1.4

1.3

0.18

0.25

nmol/l

0.87

213

(1001926) Buprenorphine [Presence] in Urine by Screen method

422

3221

1.31

6.59

2.6

2.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

363

1.95

6.59

1.3

66.43

451.17

titre

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

832

6873

1.21

6.58

1.7

1.6

22.28

21.34

u/ml

0.12

161

1450

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

333

2458

1.35

6.55

1.3

0.19

0.21

nmol/l

1.11

256

1957

(3024869) Neuronal Ab [Presence] in Serum

364

1.94

6.54

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

513

1.79

6.53

7.8

7.5

5.90

5.94

kpa

0.16

446

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

168

1095

1.53

6.50

1.7

1.5

5.78

6.11

u/l

0.25

147

927

(40765096) Chromosome analysis panel by Banding

101

580

1.74

6.48

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

421

1.87

6.48

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

523

4119

1.27

6.42

4.9

3.6

30.66

28.48

mg/l

0.70

396

2911

(3004775) Volume in Urine collected for unspecified duration

227

1577

1.44

6.40

2.5

2.3

742.54

660.61

1.46

151

1066

(3032352) Blasts [#/volume] in Cerebral spinal fluid

195

2.30

6.39

2.9

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

523

4126

1.27

6.34

2.6

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

199

1357

1.46

6.21

1.7

1.8

8.38

9.40

umol/l

0.25

154

982

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

369

2791

1.32

6.19

1.4

1.3

1.75

2.21

nmol/l

0.13

360

2677

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

243

2.13

6.17

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

243

2.13

6.17

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

526

4169

1.26

6.15

2.6

2.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

297

2.01

6.13

12.9

11.6

5.80

5.34

mmol/l

0.44

297

(36660697) Celiac disease serology panel - Serum

1622

14243

1.14

6.10

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

115

2.69

6.10

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

130

812

1.60

6.09

2.9

3.2

31.40

24.89

mu/l

0.69

119

767

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

125

775

1.61

6.04

2.2

2.3

49.52

53.14

umol/l

0.58

105

656

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

267

1932

1.38

6.00

1.5

1.4

28.39

31.13

u/l

0.75

234

1562

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

542

1.73

5.99

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.32

5.93

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

551

1.72

5.93

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

522

4154

1.26

5.91

2.6

1.9

—

(3023410) Appearance of Cerebral spinal fluid

248

1778

1.39

5.90

1.6

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

162

1072

1.51

5.89

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

146

945

1.54

5.88

1.4

1.6

7.21

10.00

ug/l

1.71

135

863

(3047185) IgG [Mass/volume] in Urine

4.98

5.83

1.1

—

38.67

—

(3016879) Cocaine [Presence] in Urine

489

3870

1.26

5.81

2.6

2.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

452

1.79

5.79

1.3

16.71

16.58

umol/l

0.09

397

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

243

2.09

5.79

1.3

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

189

1300

1.45

5.68

1.3

1.2

91.85

95.67

u/l

0.25

175

1095

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

183

1251

1.46

5.68

1.6

1.5

4.10

7.09

u/l

3.44

144

995

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

156

2.36

5.63

1.2

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

271

1989

1.36

5.60

1.6

1.4

172328.66

143164.43

e6/l

0.24

186

1319

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

107

657

1.62

5.42

1.4

1.3

3.74

3.94

umol/l

0.24

571

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

455

1.75

5.39

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

167

1135

1.47

5.37

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

244

2.04

5.36

1.1

23.11

18.85

u/l

0.58

166

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

346

2651

1.30

5.35

1.1

15.17

15.68

au/ml

0.05

555

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

464

1.74

5.33

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

129

833

1.54

5.30

1.1

1464.32

1552.51

miu/ml

0.44

129

833

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

547

1.68

5.29

1.2

113.27

110.44

0.45

485

(3026692) Albumin [Mass/volume] in Peritoneal fluid

570

1.66

5.28

1.3

1.4

15.61

13.42

g/l

1.32

425

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

173

1188

1.45

5.28

1.3

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

161

2.29

5.27

4.8

2.4

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.16

5.26

1.2

1.1

1.00

1.44

u/field

0.40

(3027944) Amphetamines [Presence] in Urine

508

4089

1.24

5.25

2.5

2.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

107

2.61

5.24

2.0

1.4

24.53

22.45

mmol/l

1.89

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

171

1174

1.45

5.23

1.2

1.1

91.28

85.39

u/l

0.47

157

1034

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

175

1207

1.45

5.22

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

183

1273

1.43

5.22

1.3

1.2

29.53

27.05

u/l

0.24

169

1046

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

111

695

1.59

5.21

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

262

1.98

5.12

1.3

1.4

8.85

271436.45

nmol/l

1.72

217

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

297

1.91

5.10

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

169

1165

1.45

5.07

1.2

1.1

35.90

25.26

u/l

1.39

159

1016

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

133

2.40

5.05

1.5

13.64

16.56

pmol/l

0.51

115

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.71

5.04

1.6

2.69

2.71

mg/l

0.01

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.71

5.04

1.6

3.51

4.40

mg/l

0.26

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.71

5.04

1.6

0.70

1.16

mg/l

0.37

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.71

5.04

1.6

0.34

1.16

mg/l

1.15

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.71

5.04

1.6

1.08

2.05

mg/l

1.05

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.71

5.04

1.6

1.48

1.99

mg/l

0.28

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.71

5.04

1.6

2.35

1.89

mg/l

0.12

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.71

5.04

1.6

0.64

3.38

mg/l

3.41

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

579

1.64

5.00

1.2

1.3

0.33

0.30

g/l

3.47

469

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

238

2.01

4.95

2.2

2.9

121.97

73.06

pmol/l

0.48

212

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17148

167804

1.08

4.90

6.1

5.5

1.95

1.97

mu/l

0.68

15927

154013

(3020911) Cortisol [Moles/time] in 24 hour Urine

583

1.62

4.87

1.7

1.3

277.00

193.77

nmol/24h

0.20

583

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

114

733

1.55

4.81

2.7

2.4

21.76

257.57

ug/l

1.62

108

697

(3020961) Endomysium IgA Ab [Titer] in Serum

916

7865

1.17

4.76

1.1

181.31

201.33

titre

0.09

199

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

511

1.66

4.74

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

348

1.80

4.73

1.8

1.7

1.18

mmol/l

0.04

331

(3035320) C reactive protein [Mass/volume] in Body fluid

213

1552

1.37

4.69

3.4

2.8

26.65

29.74

mg/l

0.67

172

1139

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.59

4.67

1.6

1.01

1.84

mg/l

0.61

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

215

1571

1.37

4.66

1.2

102.06

107.86

pmol/l

0.80

215

1571

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

7.11

4.63

1.1

1.3

1.00

2.00

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.70

4.62

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

523

1.64

4.60

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

232

1.98

4.56

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

226

1.98

4.52

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

335

1.78

4.38

1.3

1.2

—

(3008898) HLA-B27 [Presence]

601

5025

1.20

4.33

1.1

—

(3017509) Phencyclidine [Presence] in Urine

112

2.40

4.32

2.1

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

244

1.92

4.31

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

564

1.59

4.29

1.6

1.2

34.31

21.73

0.51

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

565

1.59

4.26

1.4

1.2

131.46

133.10

nmol/l

0.03

396

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

504

1.62

4.24

2.4

2.0

8.16

8.88

mg/l

0.72

419

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

415

1.68

4.16

1.1

1116.67

910.87

titre

0.82

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.25

4.14

1.1

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

223

1675

1.33

4.09

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

125

852

1.46

4.07

2.0

1.6

4.32

7.57

nmol/l

0.55

108

709

(3016038) Potassium [Moles/volume] in Urine

203

1505

1.35

4.06

1.2

33.12

34.88

mmol/l

0.50

181

1283

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

141

2.19

4.05

1.6

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

189

1389

1.36

4.01

1.1

303.81

287.59

mg/l

1.94

170

1259

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

345

1.73

4.00

2.4

1.8

2.78

2.29

ug/l

0.48

203

(3020717) Zinc [Moles/volume] in Serum or Plasma

142

996

1.42

3.98

1.6

1.5

24.23

23.11

umol/l

0.17

136

922

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

176

1281

1.37

3.97

1.2

1.1

48.82

42.54

mg/l

0.44

152

1086

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

189

2.00

3.96

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

302

1.78

3.96

2.1

1.8

62.35

52.54

pmol/l

0.16

248

(3036180) Methadone [Presence] in Urine

5.53

3.95

1.8

2.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

475

1.62

3.95

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

507

1.59

3.92

2.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

183

2.01

3.92

1.0

0.01

0.51

u/ml

1.24

115

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

573

1.55

3.83

3.0

2.5

147.81

146.50

nmol/l

0.04

505

(3036670) Protein [Mass/volume] in Synovial fluid

100

661

1.51

3.81

1.3

37.80

39.98

g/l

0.62

332

(40758292) HTLV I+II Ab panel - Serum

321

1.74

3.79

1.5

1.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

264

1.81

3.74

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

168

1228

1.36

3.72

1.1

315.38

281.72

mg/l

0.45

151

1092

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

452

1.61

3.71

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

578

6745

0.85

3.68

1.6

1.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

123

855

1.43

3.66

1.3

1.2

159.12

161.55

mmol/24h

0.12

123

855

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1405

12643

1.11

3.64

2.4

19.45

22.32

au/ml

0.63

115

1232

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

103

2.32

3.61

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

267

1.79

3.61

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

2.19

3.55

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

143

2.09

3.53

1.2

1.0

0.03

0.04

u/ml

0.65

143

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.56

3.50

1.1

1.0

0.29

0.07

u/ml

0.46

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.43

3.50

1.0

1.1

7.85

8.49

0.46

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

530

1.54

3.50

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

823

1.43

3.47

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

492

1.56

3.46

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

249

1947

1.28

3.45

1.3

1.66

1.45

nmol/l

1.99

224

1757

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.87

3.42

1.1

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.40

3.42

1.0

1.1

37.56

36.62

0.65

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.40

3.42

1.0

1.1

19.95

21.18

0.51

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7010

67227

1.06

3.42

5.7

5.8

3.57

3.67

ug/l

0.08

6288

60571

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

19118

188360

1.08

3.42

19.9

12.6

26.37

25.76

u/l

2.44

18766

182286

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

243

1.80

3.41

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

474

3974

1.19

3.40

1.3

232.88

217.60

miu/ml

0.32

143

1637

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16607

167655

0.94

3.39

4.6

4.5

1.39

1.29

mmol/l

54.24

15099

152718

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

154

1133

1.36

3.32

1.1

7.24

9.00

iu/ml

0.63

273

(3027923) C peptide [Moles/volume] in Serum or Plasma

152

1117

1.36

3.31

1.5

1.4

1.40

1.21

nmol/l

1.00

113

820

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

454

3810

1.19

3.24

2.1

1.7

1.00

0.86

nmol/l

3.79

389

3194

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

142

2.03

3.21

1.0

1.1

13.79

10.07

u/l

0.25

142

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

258

3201

0.80

3.18

1.5

1.6

960.52

1002.66

mu/l

0.24

207

2632

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

170

1.93

3.18

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

184

1.89

3.18

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1687

15451

1.09

3.10

2.5

2.3

11.20

12.97

nmol/l

15.64

1483

13820

(3020564) Creatinine [Moles/volume] in Serum or Plasma

19332

190673

1.07

3.05

40.2

23.3

84.53

80.27

umol/l

33.47

19159

188151

(3020491) Glucose [Moles/volume] in Blood

176

1340

1.31

3.04

2.3

1.9

7.50

7.04

mmol/l

0.90

125

927

(3028468) Fragments [Presence] in Blood by Light microscopy

7.47

3.04

3.5

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

209

1.81

3.02

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.67

3.02

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

112

2.13

3.02

1.2

1159.50

3564.94

ng/l

3.03

(3013637) Mi-2 Ab [Presence] in Serum

558

1.48

3.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

558

1.48

3.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

558

1.48

3.00

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

558

1.48

3.00

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

470

1.53

3.00

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

277

1.69

2.96

1.9

18.27

16.49

umol/l

0.49

277

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1281

11615

1.10

2.93

1.3

41.58

56.45

au/ml

1.56

760

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

345

2854

1.21

2.93

1.7

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

137

1013

1.35

2.91

1.2

1.1

—

1.22

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

271

1.69

2.91

1.9

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

141

1050

1.34

2.87

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

6.64

2.85

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.36

2.85

1.6

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

243

1.72

2.84

1.4

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

115

2.08

2.84

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.28

2.80

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

995

8930

1.11

2.78

1.1

1.41

7.95

u/ml

0.97

102

(3036048) Francisella tularensis Ab [Titer] in Serum

407

1.54

2.77

1.2

1.1

—

864.76

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

110

2.08

2.74

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

117

2.04

2.73

1.3

1.1

1.42

1.77

iu/ml

0.47

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

154

1173

1.31

2.70

1.1

5.09

7.68

nmol/l

0.46

228

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.19

2.69

1.4

1.2

0.32

0.68

iu/ml

1.08

(3007463) Buprenorphine [Presence] in Urine

3.43

2.67

4.1

8.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

468

1.49

2.65

2.7

3.4

7.87

8.10

mg/l

0.10

389

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

511

1.46

2.59

1.9

2.4

0.91

1.05

ug/l

0.32

485

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

113

2.03

2.57

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

375

1.54

2.57

2.1

1.6

205.02

94.76

au/ml

—

(3024316) Viscosity of Plasma

2.14

2.57

2.5

1.8

1.72

1.63

mpas

0.24

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

107

2.05

2.53

1.1

—

(3025577) Chromium [Mass/volume] in Blood

162

1257

1.28

2.50

2.2

2.33

2.32

ug/l

0.02

121

1047

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

188

1486

1.26

2.50

1.9

1.8

374.98

345.97

mu/l

0.31

155

1169

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1170

10655

1.10

2.49

1.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

185

1461

1.26

2.48

1.2

1.3

9.45

9.22

mmol/l

0.27

173

1366

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

121

903

1.34

2.48

1.1

1.05

1.10

u/l

0.59

389

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.31

2.45

1.1

1.0

0.15

0.03

u/ml

0.60

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1142

0.71

2.44

1.5

46.17

60.55

ug/l

4.60

1142

(3019768) Coxiella burnetii Ab [Presence] in Serum

116

1.97

2.41

1.4

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

248

1.65

2.41

1.6

1.7

1.00

0.88

nmol/l

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

4.98

2.39

1.0

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

211

1.70

2.38

1.7

1.3

293.33

95.42

titre

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1277

11705

1.09

2.38

1.9

2.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

323

2718

1.19

2.35

1.1

61.77

4950.62

iu/ml

0.58

508

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

157

1227

1.28

2.32

1.9

2.1

17.25

16.77

nmol/l

0.30

151

1141

(3012898) Urea [Moles/volume] in Urine

198

1.71

2.30

1.2

1.4

161.38

162.49

mmol/l

0.02

167

(3038177) Helicobacter pylori Ab [Presence] in Serum

327

2761

1.18

2.30

1.3

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

123

933

1.31

2.28

1.3

1.2

0.57

0.65

ratio

0.57

540

(3013166) Neutrophils/Leukocytes in Synovial fluid

586

1.39

2.24

1.5

1.4

60.70

57.04

0.43

499

(3027456) Digoxin [Moles/volume] in Serum or Plasma

583

5149

1.13

2.22

3.3

0.80

0.81

nmol/l

0.26

449

4153

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

115

868

1.32

2.22

2.6

2.0

38.73

39.95

g/l

1.29

115

868

(3035611) Eosinophils/Leukocytes in Synovial fluid

127

1.88

2.22

1.9

1.7

1.11

0.68

0.35

102

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

121

1562

0.77

2.20

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

398

1.48

2.20

1.3

1.1

0.62

0.82

umol/24h

0.55

185

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.08

2.19

1.4

1.6

0.57

0.14

u/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

431

1.46

2.19

1.1

1.3

1.17

1.18

mmol/l

0.12

431

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

248

1.61

2.16

2.7

2.6

0.70

0.56

u/field

0.38

248

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.06

2.14

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

163

1295

1.25

2.13

2.3

2.2

3.69

3.75

ug/l

0.04

149

1205

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.99

2.13

1.0

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

525

1.40

2.12

1.2

1.7

—

182.25

iu/ml

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

101

1.97

2.12

1.6

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.35

2.09

1.2

1.1

0.04

u/ml

0.17

(3050794) Legionella sp Ab [Presence] in Serum

174

1.72

2.09

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

291

2458

1.18

2.07

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

371

1.48

2.07

1.3

1.2

118.33

63.80

mu/l

0.74

267

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

672

1.35

2.06

3.7

3.1

29.80

28.12

umol/l

0.87

507

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.12

2.05

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

141

1108

1.27

2.04

1.5

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

291

2462

1.18

2.04

1.2

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

206

1.64

2.03

1.1

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

422

1.44

2.02

2.2

2.5

180.79

140.96

au/ml

0.25

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.16

2.02

1.1

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.80

1.98

2.3

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.95

1.97

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2224

23355

0.94

1.95

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

111

852

1.30

1.95

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

352

1.47

1.94

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

100

758

1.31

1.92

1.1

180.94

423.59

ng/l

0.94

202

(40762814) Titanium [Mass/volume] in Blood

353

1.47

1.92

2.6

2.4

3.07

3.56

ug/l

0.70

140

(3010937) Rubella virus Ab [Presence] in Serum

2.10

1.89

1.1

—

(3000285) Sodium [Moles/volume] in Blood

412

1.43

1.88

1.4

1.3

139.17

138.12

mmol/l

1.58

345

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.04

1.88

2.9

1.5

75.09

126.53

ug/l

1.30

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

204

1.61

1.85

2.0

2.1

0.80

0.98

mmol/l

0.28

132

(3008116) Ketones [Moles/volume] in Urine by Test strip

464

1.40

1.84

1.4

0.22

0.30

mmol/l

0.66

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

111

1409

0.78

1.83

2.0

1.8

—

(3009015) Lactate [Moles/volume] in Synovial fluid

236

1.56

1.83

1.2

1.3

7.69

6.30

mmol/l

0.34

108

(3033942) Copper [Moles/time] in 24 hour Urine

2.19

1.82

1.5

1.1

1.93

0.48

umol/24h

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

4.15

1.81

1.4

1.5

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.15

1.81

3.0

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

232

1951

1.19

1.79

1.5

1.4

0.36

0.32

nmol/l

0.17

166

1417

(44813793) Dust mix specific IgE antibody measurement

148

1192

1.24

1.78

1.1

—

(3034614) HLA Ag [Interpretation]

2.75

1.78

1.4

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

360

1.44

1.76

6.1

6.8

10.99

10.40

0.75

360

(3029396) Erythrocyte agglutination [Presence] in Blood

231

1.55

1.74

2.3

2.6

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.49

1.72

3.2

5.0

—

(3033086) Enterovirus Ab [Titer] in Serum

2.21

1.71

1.0

—

(3001729) Color of Synovial fluid

155

1.67

1.69

1.8

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.17

1.65

2.1

1.1

40.42

57.03

umol/24h

0.27

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

517

1.35

1.65

1.4

1.3

35.76

37.15

0.11

348

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.92

1.62

1.6

373.82

514.19

nmol/l

0.72

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

268

1.49

1.62

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

142

1.68

1.61

1.0

1.1

—

0.39

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

181

1.60

1.1

9.30

17.68

iu/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

479

4289

1.11

1.55

1.1

5.55

8.55

eliau/ml

0.96

451

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

271

1.47

1.54

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

129

1.70

1.53

1.0

5.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.32

1.51

1.2

1.0

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

184

1.57

1.51

2.5

2.0

71.22

58.94

1.09

118

(40768793) Breast Pathology biopsy report

490

4402

1.11

1.50

1.4

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

100

1.79

1.50

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

181

2129

0.84

1.48

1.5

1.4

—

(3026480) Teichoate Ab [Titer] in Serum

193

1.55

1.48

1.1

—

2.00

—

(3027874) Urate [Moles/volume] in Urine

1.99

1.46

1.4

1.1

1.54

1.72

mmol/l

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

625

1.29

1.45

1.3

1.4

15.07

15.81

pmol/l

0.66

514

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

3.11

1.43

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

140

1.64

1.42

1.0

1.3

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.91

1.41

1.1

0.16

0.06

g/l

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

164

1.58

1.40

8.7

5.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

429

1.35

1.40

2.3

2.4

6.73

7.65

mmol/l

1.98

274

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2489

23787

1.05

1.38

10.8

7.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

157

1854

0.84

1.37

1.5

56.72

60.69

ug/l

0.58

124

1517

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

321

2834

1.13

1.36

1.1

0.99

1.64

u/ml

1.99

172

1503

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.93

1.35

1.6

2.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

112

1.69

1.33

1.0

0.01

0.03

u/ml

—

(3001556) Androgen free Index in Serum or Plasma

1.86

1.32

2.4

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

183

1.52

1.31

1.0

0.01

0.69

u/ml

0.71

117

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

528

4805

1.10

1.29

2.7

2.3

164.21

107.05

ug/min

1.21

312

2781

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.49

1.29

1.7

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

144

1.59

1.29

1.1

1.2

24.50

26.34

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

646

1.26

1.28

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.77

1.28

1.0

1.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

114

1.66

1.26

1.0

0.00

0.18

u/ml

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

114

1.66

1.26

1.3

1.2

0.10

0.07

g/l

0.40

(1002224) Polysomnography panel

804

7458

1.08

1.26

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.71

1.25

1.1

1.0

3.20

3.50

u/l

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.62

1.21

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

155

1.54

1.20

1.1

6.25

6.19

mmol/l

0.15

155

(3005033) Fetal Nuchal fold Thickness US

120

1426

0.84

1.17

1.5

1.4

1.27

0.02

1003

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.87

1.16

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

17123

171615

0.97

1.16

7.5

6.9

40.40

39.83

mmol/mol

13.83

15944

159349

(3003888) Timothy IgE Ab [Units/volume] in Serum

273

2417

1.13

1.16

1.1

3.70

3.97

u/ml

0.12

145

1208

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.04

1.14

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

126

1486

0.84

1.14

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

375

4112

0.91

1.13

1.4

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.84

1.11

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

430

1.30

1.10

1.1

1.2

392.74

282.15

pmol/l

0.96

308

(3018133) Calcium [Moles/volume] in Urine

301

1.36

1.09

2.0

1.5

2.60

2.78

mmol/l

0.22

272

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

118

987

1.19

1.09

1.1

26.30

19.22

u/ml

0.47

358

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

503

1.27

1.06

3.3

1.6

43.73

225.35

pmol/l

0.67

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

149

1719

0.86

1.05

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

777

0.79

1.04

1.1

1.0

0.71

0.94

u/ml

0.27

181

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.78

1.03

1.0

5.94

4.13

u/ml

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.05

1.02

1.9

2.0

216.71

250.98

ug/l

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

410

1.29

1.01

1.1

1.0

10.10

9.15

u/ml

0.09

249

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

106

1.60

1.01

1.0

0.01

0.80

u/ml

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

124

1443

0.85

0.99

1.4

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

811

0.81

0.95

1.1

1.0

4.01

0.95

u/ml

0.39

257

(3008401) Mugwort IgE Ab [Units/volume] in Serum

261

2338

1.11

0.95

1.0

1.1

0.72

0.99

u/ml

0.64

109

990

(3033099) Centromere Ab [Titer] in Serum

467

1.26

0.95

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

132

1.51

0.95

1.7

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

108

1.57

0.94

1.1

1.2

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

258

1.35

0.94

1.2

1.3

59.44

51.74

0.39

113

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

711

1.20

0.93

1.1

6.81

6.34

u/ml

0.07

108

(3007542) Rye IgE Ab [Units/volume] in Serum

1.68

0.93

1.0

2.84

0.14

u/ml

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.61

0.92

1.0

0.01

0.22

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.61

0.92

1.0

0.14

0.57

u/ml

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.72

0.91

6.1

9.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

839

0.82

0.91

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

244

2185

1.11

0.91

1.1

0.95

1.18

u/ml

0.37

125

1085

(3027231) Wheat IgE Ab [Units/volume] in Serum

251

1.35

0.91

1.0

0.35

2.03

u/ml

0.90

207

(3016330) Potassium [Moles/time] in 24 hour Urine

251

1.35

0.91

1.3

1.2

—

84.74

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

650

1.21

0.91

1.2

13.96

11.13

mm/h

1.09

650

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

153

1737

0.88

0.90

1.4

1.15

1.21

ratio

0.40

1046

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

153

1737

0.88

0.90

1.4

1.03

0.95

ratio

0.40

1041

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.90

0.88

1.4

1.1

1.37

3.02

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

153

1733

0.88

0.87

1.4

1.18

1.16

ratio

0.09

1037

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

151

1317

1.14

0.87

1.5

—

(3006270) Folate [Moles/volume] in Blood

187

1656

1.13

0.86

1.2

320.13

347.27

nmol/l

0.75

145

1335

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

187

1.38

0.83

1.4

1.1

1.82

1.73

umol/24h

0.18

187

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

146

1.43

0.80

1.2

1.1

88.38

92.93

titre

0.13

146

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.57

0.79

11.9

8.7

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.66

0.78

1.0

1.2

—

mmol/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

177

1576

1.12

0.77

4.7

5.5

47.54

115.86

u/ml

1.57

524

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

114

987

1.15

0.76

2.3

2.1

113.88

117.62

ug/min

0.02

224

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.16

0.76

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.76

0.76

1.2

1.1

319.67

277.82

u/ml

—

(40758358) Immune stain study

1.59

0.73

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

902

8575

1.05

0.73

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

141

1.41

0.72

2.2

2.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

225

2041

1.10

0.71

1.1

4.84

3.77

eliau/ml

0.26

851

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.52

0.71

1.2

1.3

1.00

1.19

u/field

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.54

0.70

1.1

13.74

30.33

u/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

168

1.36

0.69

1.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

126

1.42

0.68

1.2

1.4

30.73

37.38

0.23

(3025130) Human papilloma virus identified in Specimen

229

2086

1.09

0.67

1.7

1.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

161

1.36

0.66

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

258

1.27

0.64

1.2

61.79

62.98

ug/l

0.15

258

(3018291) Platelet Ab [Presence] in Serum

1.72

0.63

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

102

1153

0.88

0.63

1.4

245.43

166.29

pmol/l

0.41

102

1153

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

172

1.33

0.62

1.2

1.3

0.14

0.24

nmol/l

1.29

117

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

244

0.73

0.61

1.1

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

522

5481

0.95

0.61

2.0

1.7

5.65

4.49

mg/l

1.09

437

4115

(3045683) HLA typing for celiac disease panel - Blood or Tissue

895

0.87

0.60

1.1

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.59

0.0

1.1

—

0.40

—

(3022475) Manganese [Moles/volume] in Blood

105

1.42

0.58

1.3

0.17

0.15

umol/l

0.55

105

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

218

1.28

0.58

1.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

114

1.40

0.57

1.0

0.01

0.13

u/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

649

6171

1.05

0.57

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2450

23850

1.03

0.57

5.0

5.2

31.77

32.84

5.20

1727

15574

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

132

1.36

0.55

1.7

1.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.53

0.52

1.0

0.05

1.98

u/ml

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.45

0.52

5.9

5.8

443.44

434.05

umol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

164

1781

0.92

0.52

3.3

3.0

111.88

43.20

mg/l

1.58

127

1272

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

132

1448

0.91

0.52

1.0

37.14

41.25

ng/l

0.80

1001

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

132

1445

0.91

0.50

1.0

754.49

723.75

ng/l

0.39

980

(3020650) Glucose [Presence] in Urine

628

1.14

0.50

1.7

1.6

0.00

0.04

estimate

2.47

628

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

170

1.29

0.50

5.7

6.0

8.50

8.21

0.11

170

(3013139) Helicobacter pylori Ag [Presence] in Stool

1332

12893

1.03

0.49

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

431

0.83

0.49

1.5

—

(4133840) Spirometry

452

0.84

0.48

1.4

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

179

1645

1.08

0.48

1.0

0.14

0.38

u/ml

1.08

545

(44806420) Estimation of glomerular filtration rate

197

1818

1.08

0.48

2.9

2.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

171

1.28

0.48

2.9

3.0

42.91

45.36

0.23

171

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

288

1.21

0.48

1.1

14.09

35.43

iu/ml

6.29

288

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

14644

146480

0.99

0.48

39.4

22.9

329.55

331.78

g/l

154.60

14556

145562

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

119

1074

1.10

0.48

1.5

1.6

2.31

4.35

ug/l

2.42

854

(3005011) Chlamydia sp Ab [Titer] in Serum

207

1.25

0.47

1.7

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

534

5086

1.05

0.47

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

198

1830

1.08

0.47

1.1

4.12

3.44

u/ml

0.16

790

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

132

1437

0.91

0.46

1.0

297.10

326.21

ng/l

0.76

1011

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

120

1.33

0.45

1.2

1.4

—

13226.86

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.42

0.44

1.1

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

147

1.29

0.44

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

690

0.88

0.43

1.1

1.0

0.48

0.71

u/ml

0.19

169

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

196

2090

0.93

0.43

1.3

1.2

7.87

7.48

mmol/l

0.95

171

1791

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

883

1.11

0.42

4.7

5.8

45.18

5124.40

u/ml

0.59

141

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

450

1.15

0.42

1.4

1.2

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

148

1.28

0.42

2.7

1.9

9.63

19.42

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

166

1.26

0.42

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

124

1133

1.09

0.41

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

212

1.22

0.40

1.8

1.5

0.52

0.49

e9/l

0.20

212

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.32

—

(4146454) Self-monitoring of blood glucose

223

2358

0.94

0.39

2.4

2.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

132

1.28

0.39

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

504

0.87

0.39

1.4

1.8

—

(3013762) Body weight Measured

1.38

0.38

1.8

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

149

1379

1.08

0.37

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

544

5220

1.04

0.37

2.0

1.8

39.83

43.18

nmol/l

3.43

536

5054

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

134

1.26

0.35

1.0

1.1

16.80

17.58

nmol/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

308

1.16

0.35

2.0

3.4

91.89

118.67

ng/l

0.18

100

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.39

0.35

1.0

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

1.39

0.35

1.0

1.4

1.40

0.26

—

(4034850) Laboratory test

618

5956

1.03

0.35

16.4

11.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

189

1.21

0.34

3.0

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

236

1.18

0.33

1.3

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

425

4074

1.04

0.33

2.1

1.9

192.81

200.36

pmol/l

0.73

406

3836

(3018001) Oat IgE Ab [Units/volume] in Serum

100

1.29

0.32

1.0

0.19

0.21

u/ml

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.27

0.32

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1923

18833

1.02

0.31

1.6

—

6.17

—

(3000963) Hemoglobin [Mass/volume] in Blood

19370

193157

0.99

0.30

47.1

26.8

130.20

134.01

g/l

207.98

19223

190799

(3014133) Dog dander IgE Ab [Units/volume] in Serum

206

1947

1.05

0.30

1.1

2.47

3.24

u/ml

0.45

104

939

(40765089) Chromosome analysis panel - Blood by G-banded

249

0.84

0.30

1.0

—

(3006462) Nitrate [Presence] in Urine

895

1.08

0.29

3.7

3.5

—

(3026361) Erythrocytes [#/volume] in Blood

19369

193131

0.99

0.28

46.7

26.6

4.35

4.44

e12/l

101.93

19002

187963

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

19369

193126

0.99

0.28

47.8

27.1

39.26

40.31

28.65

19206

190645

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

485

4978

0.97

0.28

1.5

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

19369

193121

0.99

0.27

46.5

26.6

91.76

91.47

14.06

19208

190721

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.24

0.27

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.21

0.26

1.4

1.2

1.49

1.35

—

(3035941) MCH [Entitic mass]

19369

193110

0.99

0.26

46.5

26.5

30.26

30.40

18.24

19209

190709

(3010813) Leukocytes [#/volume] in Blood

19374

193157

0.99

0.26

46.7

26.7

7.14

6.81

e9/l

40.46

19016

188010

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17509

174658

0.99

0.25

5.8

5.5

6.07

6.02

mmol/l

6.67

16051

159259

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.24

0.25

1.0

0.01

0.07

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.27

0.25

1.2

1.7

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

114

1.22

0.24

1.1

1.5

7.89

13.27

—

(3007461) Platelets [#/volume] in Blood

19368

193074

0.99

0.23

46.7

26.7

249.50

246.85

e9/l

5.77

19058

188676

(4211845) Urine protein measurement

105

984

1.06

0.23

3.6

3.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.24

0.22

1.0

1.1

24.76

33.91

mg/24h

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

735

1.07

0.21

1.3

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

177

0.84

0.21

1.1

1.0

8.39

7.60

u/ml

0.05

177

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

35.73

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.21

0.0

1.0

—

12.98

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

103

0.77

0.21

1.5

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

123

0.81

0.21

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

457

4436

1.03

0.21

1.2

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

5.25

—

(40762887) Creatinine [Moles/volume] in Blood

164

1.15

0.19

1.6

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

375

1.09

0.18

5.3

5.8

9.50

8.48

mmol/l

0.41

375

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.16

0.17

1.0

0.00

1.22

u/ml

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.20

0.17

1.2

1.8

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.72

0.16

1.2

1.0

—

0.16

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.15

0.16

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

110

1.18

0.16

4.3

3.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

358

0.92

0.16

1.1

1.0

0.66

1.65

u/ml

0.77

180

(3027570) Oxalate [Moles/time] in 24 hour Urine

102

1.17

0.14

1.9

1.5

367.17

315.03

umol/24h

0.30

102

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

540

0.94

0.14

1.7

0.87

1.73

u/ml

0.92

136

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

488

1.06

0.13

1.8

1.6

10.43

9.11

ug/l

0.85

488

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5432

53874

1.00

0.11

4.7

21.67

22.25

2.11

2793

27482

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

310

0.93

0.11

1.1

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

116

1119

1.03

0.11

6.3

7.0

35.01

110.18

ug/l

1.32

731

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

220

1.09

0.10

1.0

80.63

81.20

ug/l

0.02

161

(3011335) Digoxin [Mass/volume] in Serum or Plasma

192

1.09

0.10

2.3

0.72

0.66

ug/l

0.29

192

(4094501) Cardiovascular stress test using bicycle ergometer

543

5343

1.01

0.09

1.1

—

(4212803) Bone marrow aspirate examination

194

1.08

0.08

1.1

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

1.12

0.07

1.0

1.4

0.17

1.15

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.07

0.07

1.0

1.1

222.45

258.16

nmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

657

1.03

0.06

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3994

39678

1.00

0.04

3.3

0.82

0.79

ug/l

0.57

2840

26826

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

190

0.94

0.04

1.3

1.8

—

(3045462) Protein/Creatinine [Ratio] in Urine

151

1.05

0.02

2.6

3.2

85.45

41.45

mg/mmol

0.41

135

(46235168) Fasting glucose [Moles/volume] in Blood

211

0.99

0.00

2.4

2.5

8.11

7.37

mmol/l

—

102

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

138

1.01

0.00

1.1

1.0

3.22

0.31

u/ml

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.98

0.00

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.4

—

137.60

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.00

-0.00

1.2

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

15.78

—

(4038314) Semen analysis, post vasectomy

1.00

-0.00

1.0

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

170.60

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.98

-0.00

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.94

-0.00

1.0

1.1

8.28

8.16

mmol/l

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.1

—

2.86

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.98

-0.00

1.3

1.2

45.33

69.64

ug/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.01

-0.00

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_DVTANDPULM – DVT of lower extremities and pulmonary embolism

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

DVT of lower extremities and pulmonary embolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for DVT of lower extremities and pulmonary embolism (I9_DVTANDPULM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints